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The neutrophil is the first haemopoetic cell to arrive at the site of infection.  In acute 
respiratory distress syndrome (ARDS), dense neutrophilic infiltrates are found in the 
lung in response to bacterial infection as well as generalised inflammatory stimuli, 
such as pancreatitis.  At sites of infection, phagocytosis of bacteria by neutrophils 
enhances their subsequent apoptosis and clearance by macrophages however at 
inflammatory sites, the lifespan of the neutrophil is influenced by both pro- and anti-
apoptotic factors in the inflammatory milieu.  Furthermore subsequent macrophage 
phagocytosis of apoptotic neutrophils induces the macrophage to switch to an anti-
inflammatory phenotype thereby hastening resolution of inflammation. 
The Fas death receptor pathway is important in T lymphocyte apoptosis but its role 
in neutrophil apoptosis is controversial.  We have shown that neutrophils express the 
Fas receptor (CD95) on their surface but there is no evidence of expression of its 
natural ligand (FasL).  An agonistic anti-Fas monoclonal antibody (CH-11) 
accelerated neutrophil apoptosis under certain culture conditions.  
Lipopolysaccharide (LPS) originating from Gram-negative bacteria is often found at 
sites of inflammation.  We have shown that LPS attenuated CH-11 - induced 
neutrophil apoptosis unless the Fas/FasL death receptor pathway was activated prior 
to the LPS signalling pathway.  This LPS-mediated attenuation did not involve the 
p42/44 ERK, protein kinase C or phosphatidylinositol 3-kinase signalling pathway 
however the p38 MAPK and NF-κB pathway appeared to be partially involved.  We 
have shown that neutrophils express the protein cFLIPs and that CH-11 and 
inflammatory mediators altered its expression. 
Although macrophages are principally phagocytes, they are also important in 
determining the composition of the milieu at an inflammatory site.  Macrophages 
have been shown to express FasL which can be shed and may contribute to the pools 
of sFasL found in the bronchoalveolar lavage fluid (BALF) in ARDS patients.  We 
have shown that the conditioned supernatants from LPS-activated macrophages 
induced neutrophil apoptosis at early time points.  The pro-apoptotic activity was 
mediated by TNF-α and was found in the fraction containing proteins with molecular 
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 x
weights greater than 50kD.  Macrophage phagocytosis of apoptotic neutrophils 
suppressed TNF-α production by LPS-activated macrophages and this was associated 
with loss of the pro-apoptotic activity. 
In summary, our data suggest that Fas/FasL fratricide does not appear to be involved 
in spontaneous neutrophil apoptosis.  However LPS attenuates Fas-induced apoptosis 
unless the Fas/FasL death receptor pathway is activated prior to LPS signalling 
pathways.  The signalling pathways involved in this attenuation are not clear but may 
involve cellular FLIP.  Furthermore, activated macrophages secrete inflammatory 
mediators and at early time points, TNF-α appears to be the most important in 
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1.1 The Cells 
Macrophages reside in the lung quiescent but armed to deal with invading organisms 
while neutrophils marginate in the lung vasculature, quiescent but ready to mobilise 
to sites of infection or inflammation.  The role of these cells, their response to 
inflammatory mediators and their role in the resolution of inflammation will be 
explored. 
1.2 The Lung 
The vertebrate lung is essential to life; physiologically, gas exchange is its main 
function however immunologically, its role in innate immunity is also important.  
The lungs innate immune system is tightly regulated.  It has to remain quiescent to 
allow daily exposure to ubiquitous non-virulent organisms while at the same time 
being able to mount immune responses.  Furthermore, it must prevent over-zealous 
immune or inflammatory responses which result in tissue damage. 
Acute Respiratory Distress Syndrome (ARDS) is an example of lung inflammation 
secondary to both direct and indirect lung injury.  While pneumonia and aspiration of 
gastric contents are the commonest causes of direct lung injury, sepsis, severe trauma 
with shock and multiple transfusions are the commonest causes of indirect lung 
injury.  Overall sepsis is the leading cause of ARDS accounting for up to 40% of the 
total cases (Ware and Matthay, 2000).  Patients with ARDS, in the early stages, are 
profoundly hypoxaemic and refractory to oxygen therapy.  This reflects disruption of 
the blood-air barrier caused by the diffuse alveolar damage (figure 1.1).  In this acute 
or exudative phase, neutrophils, macrophages, erythrocytes, hyaline membranes and 
protein-rich oedema are found in the alveolar spaces.  This is largely secondary to 
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widespread injury to the endothelium and alveolar epithelium.  This inflammatory 
process can either resolve or progress to a fibrotic phase.  In the fibrotic phase, 
histologically there is evidence of fibrosis, an acute and chronic inflammatory cell 
infiltrate and only partial resolution of the pulmonary oedema. 
In ARDS and acute lung injury (ALI), which is a less severe form of ARDS, there is 
debate in the scientific community regarding the pathogenic role of the neutrophil.  It 
has been argued that they are merely, a stereotypical part of the inflammatory 
response.  However, on balance, the evidence suggests that the neutrophil plays a 
central role.  Although neutropenic patients develop ARDS (Laufe et al., 1986), their 
pulmonary function worsens during recovery from the neutropenia (Azoulay et al., 
2002).  Furthermore, in animal models, depletion of neutrophils prior to the 
pathogenic stimulus, reduces the extent of the lung injury (Heflin and Brigham, 
1981; Abraham et al., 2000). 
Neutrophils may exacerbate lung injury in several ways; secondary necrosis of 
neutrophils, due to delayed neutrophil clearance, results in release of their toxic 
granules and thereby exacerbation of the tissue injury and secondly, activated 
neutrophils in the inflamed tissue secrete pro-inflammatory mediators.  
Bronchoalveolar lavage fluid (BALF), from patients with ARDS, delays the 
apoptosis of peripheral blood neutrophils in vitro.  Blocking antibodies have shown 
that most of this anti-apoptotic activity is due to the cytokines granulocyte - colony 
stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor 
(GM-CSF) (Matute-Bello et al., 1997).  However BALF also contains other 
cytokines, including interleukin-1β (IL-1β) and tumour necrosis factor-α (TNF-α) 
which are the main pro-inflammatory cytokines secreted by an activated neutrophil 
(Park et al., 2001). 
In animal models, lung injury can be induced by several methods including 
intratracheal administration of endotoxin.  Anti-inflammatory strategies targeting the 
neutrophil, for example anti-oxidant therapies, inhibit the development of ALI after 
endotoxin administration by reducing neutrophil infiltration and secretion of pro-
Chapter 1 
 3
inflammatory cytokines.  In turn, this is associated with a reduction in oedema 
formation and extent of lung injury (Blackwell et al., 1996; Liu et al., 1997). 
In health, apoptotic neutrophils are only occasionally seen in peripheral blood or 
bronchoalveolar lavage fluid due to their rapid phagocytosis by macrophages.  
Neutrophil clearance appears to be important in resolution of ALI in vivo.  In the 
resolution phase of an oleic acid model of ALI in rats, apoptotic neutrophils were 
seen and were cleared, by phagocytosis, by alveolar macrophages (Hussain et al., 
1998). 
In the intensive care setting, it has been observed that ventilator-associated 
pneumonia is more common in patients with ARDS compared to those without 
ARDS (Dreyfuss and Ricard, 2005).  There is evidence to suggest that the systemic 
inflammatory response is also immunosuppressive and may therefore increase 
susceptibility to bacterial and fungal infections (Munford and Pugin, 2001).  This is 
supported by the observation that in an animal model of endotoxin-induced ALI, the 
alveolar macrophages retrieved in BALF from ALI animals exhibited poorer 
bacterial phagocytic activity than those retrieved from control animals (Jacobs et al., 
1986). 
1.3 The Neutrophil  a professional phagocyte 
The principal role of the neutrophil in the cellular orchestra of the innate immune 
system is that of a professional phagocyte, the importance of which was first realised 
by Elie Metchnikoff in the 1880s.  The neutrophil phagocytoses invading bacteria 
and in so doing accelerates its own apoptosis (Watson et al., 1996). 
1.3.1 Neutrophil Maturation 
The neutrophil starts life in the bone marrow as a pluripotent cell of the myeloid 
lineage and over a two week period passes through six different stages of 
differentiation and maturation: myeloblast, promyeloblast, myelocyte, 
metamyelocyte, non-segmented (band) neutrophil and segmented neutrophil.  The 
segmented neutrophil is the mature, terminally differentiated, cell that exits the bone 
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marrow.  It contains cytoplasmic granules and a lobulated chromatin-dense nucleus 
with no nucleolus and is therefore also known as a polymorphonuclear leukocyte 
(PMN).  It remains in the circulation, in a quiescent state, for 4 to 10 hours before 
marginating and entering tissues where it survives for 1 to 2 days (Breton-Gorius and 
Reyes, 1976). 
1.3.2 Neutrophil Recruitment 
In quiescent states, there are two pools of neutrophils, a circulating pool and a 
marginated tissue pool.  Margination occurs in narrow, mainly pulmonary capillaries 
and in response to a vasodilating stimulus such as exercise the neutrophils re-enter 
the circulating pool resulting in a relative neutrophilia.  An inflammatory stimulus 
will also induce a leucocytosis by stimulating the bone marrow to produce more 
polymorphonuclear cells (Witko-Sarsat et al., 2000). 
In response to bacterial products and pro-inflammatory cytokines, neutrophils 
sequester in the lungs by inducing a conformational shape change such that the 
neutrophil becomes trapped even in vasodilated capillaries.  One hypothesis is that, 
in response to G-protein-coupled seven-transmembrane (serpentine) receptor 
ligation, soluble G-actin assembles into an outer ring of F-actin filaments (Worthen 
et al., 1989; Hogg and Walker, 1995) which reduces neutrophil deformability.  
Mature circulating neutrophils constitutively express L-selectin (CD62L) and it also 
appears to be important in pulmonary sequestration; in L-selectin deficient mice, 
there was only a transient neutropenia in response to infused complement fragments 
compared to the circulating neutropenia observed in wild type animals (Doyle et al., 
1997). Furthermore, an L-selectin blocking monoclonal antibody reduced alveolar 
capillary neutrophil sequestration in a rabbit endotoxin model of ALI (Kuebler et al., 
2000).  L-selectin signalling may also contribute to the change in neutrophil 
deformability.  In a recent study, L-selectin cross-linking induced actin assembly and 
increased neutrophil retention in an in vitro model of the microvascular capillary bed 
(Simon et al., 1999). 
At sites of inflammation, inflammatory mediators, including histamine, thrombin and 
oxygen radicals, induce the endothelial expression of P-selectin (CD62P) which 
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interacts primarily with P-selectin glycoprotein ligand-1 (PSGL-1) present on 
neutrophils (Moore et al., 1995; Hidari et al., 1997).  Later, locally produced TNF-α 
and interleukin-1 (IL-1) stimulate the endothelium to synthesize and express E-
selectin (CD62E) (Bevilacqua and Nelson, 1993; Cronstein and Weissmann, 1993).  
The endothelial selectins bind to their ligands on the neutrophil which include sialyl-
Lewisx (sLex, CD15s) and PSGL-1, forming a tight but rapidly dissociating bond, 
which along with the shear stress of blood flow gives rise to the intermittent tethering 
motion of neutrophil rolling (Bevilacqua and Nelson, 1993; Albelda et al., 1994).  In 
addition, inflammatory stimuli, including interleukin-8 (IL-8), fMet-Leu-Phe (fMLP, 
a bacterial cell wall-derived tripeptide) and complement factor C5, activate the 
neutrophil thereby inducing the surface expression of CD11/CD18 (β2 integrin).  At 
the same time, activation induces a conformational shape change of the ligand 
CD11/CD18 which then has greater avidity for its receptor, intercellular adhesion 
molecule type 1 (ICAM-1) (Williams and Solomkin, 1999).  ICAM-1 expression, on 
post-capillary venules and also capillary endothelial cells in the lung, is upregulated 
by the inflammatory stimuli.  This stable bond between β2-integrins and ICAM-1 
allows neutrophil adhesion to the endothelium. 
However the individual role of adhesion molecules in neutrophil recruitment appears 
to depend upon the stimulus.  In murine streptococcal pneumonia, neutrophil 
emigration is CD18-independent while in murine pneumonia secondary to  
Escherichia coli and Pseudomonas aeroginosa, it is CD-18 dependent (Mizgerd et 
al., 1999; Doerschuk et al., 2000).  Furthermore in murine streptococcal pneumonia 
neutrophil emigration was also independent of E-, P- and L-selectin (Mizgerd et al., 
1996).  In humans, the importance of adhesion molecules in neutrophil recruitment is 
apparent in patients who have leucocyte adhesion deficiency-I (LAD-I) due to a 
congenital deficiency of CD18.  These patients die prematurely (often before the age 
of 10) from recurrent skin and mucosal infections due to a paucity of tissue 
neutrophils while at the same time having a relative blood leucocytosis (Anderson et 
al., 1985; Lekstrom-Himes and Gallin, 2000).  It has also become apparent that 
neutrophils can respond heterogeneously.  Neutrophils released from bone marrow in 
response to acute streptococcal pneumonia express a higher concentration of L-
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selectin and migrate more slowly into the inflammatory site than circulating 
neutrophils (Lawrence et al., 1996). 
1.3.3 Neutrophil Priming 
Neutrophils can be primed such that subsequent stimulation provokes a larger 
response than a non-primed cell.  Priming can result in biochemical changes within 
the cell (Walker and Ward, 1992) including intracellular generation of cytokines or 
lipid mediators, for example, leukotriene B4 (LTB4) and platelet activating factor 
(PAF) (Doerfler et al., 1989) so that the cells have increased ammunition when 
activated.  Inflammatory mediators including lipopolysaccharide (LPS) and fMLP, 
prime neutrophils to induce a shape change as a result of modifications to their 
intracellular actin (Worthen et al., 1989).  This is a key step in making neutrophils 
less deformable.  However various processes involved in sequestration of neutrophils 
(Kitagawa et al., 1997) can themselves lead to priming including crosslinking of 
neutrophil adhesion receptors (Waddell et al., 1994; Liles et al., 1995). 
Neutrophils have many different types of receptor on their surface.  Serpentine 
receptors are G-protein-linked seven transmembrane receptors.  There are also single 
transmembrane domain receptors that require immobilization or crosslinking such as 
immunoglobulin (Fc) receptors and integrins and then there are single 
transmembrane receptors which bind growth-related cytokines such as TNF-α or 
GM-CSF.  Triggering of the former two receptor pathways often has a dual effect; 
priming at low concentrations of the ligand and activation at higher concentrations.  
However, triggering of the single transmembrane receptor pathway for growth-
related cytokines tends to result in priming alone (Hallett and Lloyds, 1995).  A two 
stage biological process however prevents inappropriate activation of neutrophils in 
the bloodstream. 
1.3.4 Transendothelial Migration 
In the lung, transendothelial neutrophil migration from the capillary bed, in response 
to inflammatory stimuli, occurs mainly by penetrating interendothelial junctions or at 
bicellular or tricellular corners of endothelial cells.  However a transcellular route has 
also been described (Burns et al., 2003).  Under the influence of a chemotactic 
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gradient, neutrophils penetrate the endothelial layer (diapedesis) and migrate through 
the interstitium.  Diapedesis occurs predominantly between endothelial cells and both 
in vitro and in vivo data suggest that platelet-endothelial cell adhesion molecule 1 
(PECAM-1, CD31) is important in this step.  CD31 is a member of the 
immunoglobulin superfamily and has now been linked to many biological functions 
(Jackson, 2003).  Its role in migration involves a homotypic interaction between 
CD31 on the neutrophil and CD31 on the endothelial cell resulting in transient 
remodelling of the junction (Muller et al., 1993).  The interaction of CD31 on 
endothelial cells with CD31 on transmigrating neutrophils also leads to upregulation 
of α6 integrins and recently both α6 integrins and neutrophil elastase have been 
shown to be important in neutrophil migration through the perivascular basement 
membrane (Wang et al., 2005). 
1.3.5 Phagocytosis 
Microorganisms can either be recognized directly by pattern recognition receptors on 
the neutrophil surface or more commonly the microorganisms are first opsonized by 
IgG antibodies or complement and then recognized by neutrophil Fcγ receptors and 
complement receptors (CR1, CR3) respectively.  Recognition of the microorganism 
and binding to the neutrophil surface stimulates phagocytosis. 
This involves a complex series of morphological and biochemical processes which 
differ depending whether phagocytosis is antibody-mediated or complement-
mediated.  The antibody-coated microorganism is initially engulfed by an 
invaginating plasma membrane to form a phagocytic vesicle.  Thereafter, the 
contents of neutrophil granules, usually in combination with toxic substances 
generated during the respiratory burst, kill the engulfed bacteria.  The importance of 
the respiratory burst can be seen in patients with chronic granulomatous disease who 
have an absence of or abnormality in, a component of the nicotinamide adenine 
dinucleotide phosphate (NADPH) oxidase system.  The neutrophils of these patients 
are able to phagocytose bacteria but they are unable to kill their involuntary guests. 
Patients thus die prematurely from bacterial infections, particularly with catalase 
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positive bacteria such as Staphylococcus aureus that can intrinsically break down 
hydrogen peroxide (Winkelstein et al., 2000). 
More recently, it has been observed that mice deficient in two neutrophil granule 
proteases (cathepsin G and elastase) were more susceptible to fungal and bacterial 
infections.  Similarly in vitro, neutrophils treated with protease inhibitors were 
unable to kill ingested Candida albicans and Staphylococcal aureus   Furthermore, 
the mice lacking cathepsin G and elastase succumbed to infection with these 
organisms despite their neutrophils having a fully functional respiratory burst.  This 
challenged the accepted dogma that hypochlorous acid is the main microbicidal 
product in the phacocytic vesicle.  Reactive oxygen species (ROS), generated by the 
respiratory burst and released into the endocytic vacuole, create a highly negatively-
charged environment.  The accompanying release of the neutrophil acidic granules is 
insufficient for neutralisation and it is therefore accompanied by an influx of 
positively charged potassium ions in a pH dependent manner.  This increased ionic 
strength favours the release of the aforementioned cationic proteases from their 
resting state, bound to anionic proteoglycan matrix.  Furthermore, the resulting 
alkaline pH of the endocytic vacuole is optimal for the function of these proteases 
which in their activated state, contribute to microbial killing (Reeves et al., 2002).  
1.3.6 The Respiratory Burst 
Neutrophil activation results in a large increase in the concentration of cytosolic free 
calcium (Ca2+) that triggers NADPH oxidase to form from its membranous and 
cytosolic components.  This complex enzyme is composed of at least five members 
that are dissociated and thus inactive in quiescent neutrophils.  Upon activation, the 
cytosolic components translocate to the plasma membrane to assemble the active 
oxidase.  Activation of this oxidase requires a large increase in cellular oxygen 
consumption termed the respiratory burst (Clark, 1999).  During this process, oxygen 
is reduced by NADPH oxidase to the univalent superoxide anion.  This is converted 
by superoxide dismutase to hydrogen peroxide.  Although hydrogen peroxide is itself 
toxic, it can interact with myeloperoxidase (MPO) found in neutrophil azurophil 
granules to form hypochlorous acid that is metabolised to hypochlorite and chlorine.  
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Hypochlorous acid is 100 to 1000 times more effective then hydrogen peroxide.  
Hydrogen peroxide, catalysed by iron (Fe2+) also decomposes to the hydroxyl radical 
that is another powerful and important microbicidal reactive oxygen intermediate 
(ROI) but its importance in neutrophils is controversial (Rosen and Klebanoff, 1979; 
Ward et al., 1983). 
It is well documented that murine neutrophils generate nitric oxide (NO) in response 
to cytokines (Nathan and Hibbs, 1991) however it is controversial whether resting or 
activated human neutrophils produce reactive nitrogen species (Yan et al., 1994; 
Padgett and Pruett, 1995; Evans et al., 1996; Wheeler et al., 1997).  The differences 
in studies may be due to experimental conditions and technical difficulties in 
measuring NO in vitro.  
1.3.7 Neutrophil Granules 
Neutrophils contain three different types of granules and also secretory vesicles.  
Their content and function is shown in table 1.1.  The granules are formed 
sequentially during neutrophil maturation in the bone marrow with primary granules 
being formed first at the myeloblast stage, secondary at the myelocyte stage, tertiary 
at the band cell stage and secretory vesicles at the segmented stage, of development 
(Borregaard and Cowland, 1997). 
The ease with which these granules are subsequently mobilized in the mature cell is 
in the reverse order of their development.  Secretory vesicles are mobilized in 
response to inflammatory mediators to induce surface expression of receptors, for 
example the β2 integrins, which as discussed above are important in neutrophil 
adhesion to endothelium.  Thereafter the tertiary granules are mobilized; gelatinase is 
thought to be important in neutrophil migration as its substrates include collagen IV 
(found in basement membranes) and collagen V (an important constituent of 
extracellular matrix).  The primary granules can be further subdivided into those that 
contain defensins and those that do not.  The latter granules develop first during 
neutrophil bone marrow maturation and subsequently they are mobilized last.  It is 
likely that there is minimal extracellular release of the defensin-poor granules under 
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normal physiological conditions as they principally discharge their toxic contents 
into the phagosome (Sengelov et al., 1995). 
Two rare diseases with granule deficiencies illustrate their importance to normal host 
immunity.  Patients with Chediak-Higashi disease suffer from recurrent bacterial 
infections as a result of mutations in their Lyst gene that encodes a cytoplasmic 
protein important in lysosomal trafficking; their neutrophils contain giant granules 
that result from primary and secondary granule fusion.  Recurrent bacterial infections 
are also seen in patients suffering from specific granule deficiency; their neutrophils 
lack secondary granules and defensins (Lekstrom-Himes and Gallin, 2000). 
Table 1.1  Neutrophil Granules 
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1.3.8 Neutrophils and Host Defense 
Bactericidal/permeability increasing protein (BPI) is a 55kDa protein, found in the 
primary granules, that has both LPS neutralizing activity (by binding to the Lipid A 
moiety of LPS) (Weersink et al., 1993) and bactericidal activity for specifically 
Gram-negative bacteria (Elsbach and Weiss, 1993).  BPI is bactericidal, as the name 
suggests, by enhancing bacterial membrane permeability and stimulating hydrolyses 
of membrane phospholipids by phospholipase (Elsbach, 1998). Furthermore BPI 
enhances Gram-negative bacteria phagocytosis (via neutrophil complement 
receptors) by accelerating their opsonisation by complement fragments (Nishimura et 
al., 2001).  Recombinant BPI has been used with some success, in Phase III clinical 
trials, in children with meningococcal septicaemia.  There were fewer amputations in 
the treatment group and the functional status of those in the treatment group was 
higher following the illness (Levin et al., 2000). 
Defensins are 3- to 5-kDa cationic peptides of which there are four α-defensins in the 
primary granules of human neutrophils.  They kill microorganisms by increasing 
their membrane permeability and act synergistically with BPI against Gram-negative 
bacteria.  Defensins may also be involved in the transition from innate to adaptive 
immunity.  Neutrophil α- and β-defensins are chemotactic for T cells and immature 
dendritic cells (Ganz et al., 1990).  Furthermore antigen-specific responses are 
enhanced by human α-defensins. 
Cathepsin G, in addition to its direct antimicrobial effect, has also been shown to 
have chemotactic activity for monocytes (MacIvor et al., 1999).  Furthermore, 
lysozyme not only cleaves peptidoglycans that form bacterial cell walls, it can also 
kill bacteria non-enzymatically (Ganz et al., 1986).  Lactoferrin from secondary 
granules sequesters iron essential for microbial respiration.  Secretory leukocyte 
protease inhibitor (SLPI) via its N-terminal domain has some antimicrobial activity 
in vitro against both Gram-negative and Gram-positive bacteria (Sallenave, 2002).  
The C-terminal domain is an inhibitor of neutrophil elastase and may also be 




Kerr, Wyllie and Currie in 1972 coined the term apoptosis to describe a distinctive 
type of cell death, programmed cell death.  The features of an apoptotic body are 
marked condensation of both nucleus and cytoplasm, nuclear fragmentation and 
separation of protuberances that form on the cell surface to produce many 
membrane-bounded, compact but otherwise well-preserved cell remnants of greatly 
varying size (Kerr et al., 1972).  The term apoptosis itself originates from the Greek 
word for falling leaf. 
Apoptosis is important both developmentally and in maintenance of normal tissue 
structure and function.  For example, disruption of normal apoptotic pathways is an 
important mechanism by which cells transform and acquire malignant potential.  
Furthermore, in the immune system, the mode of cell death induced by cytotoxic T 
lymphocytes is apoptotic.  The apoptotic mode of cell death is important as it allows 
senescent and potentially toxic cells to be cleared without inciting an inflammatory 
or immune response.  In contrast necrosis, classically illustrated in the form of red 
blood cells being placed in hypotonic medium, such as water, involves disruption of 
their cellular membranes and release of haemoglobin.  Loss of cellular membrane 
integrity allows release of potentially toxic intracellular contents, as described earlier 
in terms of the neutrophil (Haslett, 1992).  As with most scientific principles, 
necrosis and apoptosis are at two ends of the spectrum and there is probably a 
continuum with less definite modes of cell death in between. 
Mammalian cells have two main routes to apoptosis: the internal and the external 
pathway.  The external pathway is mediated upstream by death receptors while the 
internal pathway is mitochondria dependent.  Downstream the pathways converge on 
a group of proteins, the final common pathway. Some of these key proteins have 
been identified.  The DNA ladder nuclease (caspase-activated DNase or CAD) forms 
an inactive complex with an inhibitory subunit known as ICAD (Nagata, 2000).  
Caspase-3 cleaves ICAD resulting in the release and activation of CAD (Liu et al., 
1997; Enari et al., 1998; Sakahira et al., 1998).  Caspase-mediated cleavage of the 
nuclear lamins are responsible for nuclear shrinkage and budding (Rao et al., 1996; 
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Buendia et al., 1999) while cleavage of cytoskeletal proteins, fodrin and gelsolin, 
results in loss of cell shape (Kothakota et al., 1997).  Membrane blebbing is a 
function of p21-activated protein kinase 2 (PAK2), and it is activated by caspase 
cleavage between the negative regulatory subunit and the catalytic subunit (Rudel 
and Bokoch, 1997). 
1.4.1 Caspases 
Caspases, a group of cysteine proteases, are central to the neutrophils apoptotic 
machinery.  These proteins are phylogenetically conserved having CED homologues 
in the worm Caenorrhabis elegans.  Their catalytic centre has a highly conserved 
pentameric sequence, which includes a cysteine residue.  They cleave substrates after 
aspartic acid residues and the four residues amino-terminal to the cleavage site, 
confer substrate specificity (Earnshaw et al., 1999).  Caspases involved in apoptosis 
can be divided into two groups, initiator and effector caspases.  Initiator caspases 
include caspase-2, -8, -9 and -10; their autoactivation is tightly regulated.  Effector 
caspases include caspase-3, -6 and -7; they are activated by initiator caspases.  
However some caspases, including caspase-1 or interleukin-1β- converting enzyme 
(ICE), are involved in both apoptotic and inflammatory pathways (Rowe et al., 
2002).  Caspases, including caspase 1; 3; 4 ; 8 and 10 are present in neutrophils 
(Yamashita et al., 1999). 
1.4.2 The internal apoptotic pathway 
Mitochondria, the powerhouse of the cell, are important in apoptosis.  Furthermore 
cytochrome c, the electron carrier, is central to this pathways machinery.  It is 
released into the cytosol, in response to cellular damage and stress, where it interacts 
with apoptotic protease-activating factor 1 (Apaf-1) to form the apoptosome (Li et 
al., 1997).  This induces oligomerization of Apaf-1 and the complex is then able to 
recruit and subsequently activate caspase 9. Triggers include radiation and cytotoxic 
drugs. 
Neutrophils are known to have structures which resemble mitochondria (Maianski et 
al., 2002).  Recent research has confirmed that although human neutrophils have 
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only small amounts of cytochrome c, the Apaf-1 dependent pathway is important in 
their apoptosis (Murphy et al., 2003). 
Cytochrome c release from the mitochondria is regulated by the Bcl-2 family of 
proteins (Reed et al., 1996).  Although there are conflicting results in the literature, it 
is now generally agreed that human neutrophils constitutively express pro-apoptotic 
proteins, Bax, Bid, Bak and Bad but do not express the anti-apoptotic protein Bcl-2 
(Akgul et al., 2001). 
1.4.3 Death Receptors and the external apoptotic pathway 
Death receptors are a subset of the tumour necrosis factor receptor (TNFR) family 
characterized by an intracellular death domain.  The receptors are type-1 
membrane proteins while their ligands are type-2 membrane proteins. The 
extracellular C termini of the type-2 membrane proteins must homotrimerise to form 
the active ligand.  The ligands can exert their function in either a membrane-bound 
form or can be proteolytically cleaved to a soluble form.  Binding of the trimerised 
ligand to its receptor triggers an intracellular signalling cascade. 
1.4.4 The Fas/FasL death receptor pathway 
In 1989, a monoclonal antibody, anti-Fas antibody, was first described.  It had been 
raised against a human surface antigen using human diploid fibroblast FS-7 cells as 
the immunogen (Yonehara et al., 1989).  Subsequently, the Fas antigen (CD95) was 
found to be ubiquitously expressed in human cells.  In the same year, the monoclonal 
antibody Apo-1 was also described, although its antigen was initially found on only 
activated or malignant lymphocytes (Trauth et al., 1989).  Yonehara et al (1989) 
demonstrated that anti-Fas antibody, when combined with interferon-γ, killed cells 
expressing the Fas antigen. 
The nucleotide sequence of the Fas antigen was discovered using a complementary 
DNA (cDNA) library; the sequence molecularly coded for a 319 amino acid 
polypeptide (Itoh et al., 1991).  Its extracellular domain showed homology to human 
tumour necrosis factor receptors. When murine cells were transformed with human 
Fas antigen cDNA and treated with anti-Fas antibody, they underwent apoptosis.  In 
Chapter 1 
 15
1993, the ligand (FasL) was identified in a cytotoxic T lymphocyte hybridoma which 
killed Fas+ but not Fas- cells (Suda et al., 1993). 
Mutants of the MRL mouse strain which develop lymphadenopathy and 
splenomegaly have been described (Andrews et al., 1978); an autosomal recessive 
mutation on mouse chromosome 19 was found in the mutant referred to as lpr 
(Watanabe et al., 1991) while an autosomal recessive mutation on mouse 
chromosome 1 was found in the mutant referred to as gld (Ramsdell et al., 1994; 
Takahashi et al., 1994; Hahne et al., 1995).  It is now known that the lpr mutation 
truncates transcription of the gene encoding Fas while the gld point mutation, near 
the C terminus of the coding region for FasL, abolishes the ability of FasL to bind to 
Fas (Nagata and Suda, 1995).  A human lymphoproliferative syndrome has also been 
described associated with mutations in the Fas gene on human chromosome 10 
(Bettinardi et al., 1997). 
The Fas/FasL interaction is primarily important in T lymphocyte development and 
homeostasis.  Positive and negative selection in the thymus, as part of T cell 
development, appears to be normal in the lpr/gld mice however clonal deletion of 
autoreactive T cells in the periphery appears to be aberrant.  Furthermore, cytotoxic 
T lymphocytes (CTL) appear to use both the perforin/granzyme and Fas/FasL 
pathways to mediate their cytotoxic effect (Krammer, 2000). 
It has also been suggested that the expression of FasL in the eye and Sertoli cells of 
the testis confers immune privilege by killing invading immune cells (Bellgrau et al., 
1995; Griffith et al., 1995).  Transplant immunologists were obviously excited by 
this discovery and subsequently myoblasts expressing FasL were shown to protect 
transplanted pancreatic islet cells (Kang et al., 1997).  Furthermore, FasL expression 
on colonic tumour cells induced cell death in a human T-cell leukaemia cell line 
(Seino et al., 1997).  Several studies then emerged which refuted the established 
paradigm that FasL is important in immune privilege.  When pancreatic islet cells 
expressing FasL were transplanted, the FasL expressing cells rather than protecting 
the islet cells from rejection, resulted in more rapid rejection due to infiltrating 
neutrophils (Kang et al., 1997).  Membrane-bound FasL (40kda) is cleaved by matrix 
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metalloproteases to a 26-29kDa soluble form (sFasL) (Kayagaki et al., 1995).  It has 
been shown that while human sFasL is chemotactic for mouse and human 
neutrophils, it does not induce their apoptosis (Ottonello et al., 1999).  The 
generation of sFasL reduces expression of the active membrane-bound form and as 
sFasL can bind to Fas without inducing apoptosis, it is also a natural antagonist 
(Schneider et al., 1998).  Thus, it was proposed that sFasL, cleaved from the 
transplanted islet cells, induced neutrophil chemotaxis.  These neutrophils, in turn, 
were primarily responsible for the islet cell destruction.  It has also been suggested 
that FasL-tumour expressing cell lines indirectly augment neutrophil infiltration by 
inducing secretion of interleukin-1β (Il-1β) from neutrophils or by activating resident 
macrophages to secrete pro-inflammatory cytokines (Muzio et al., 1996).  FasL-
tumour expressing cell lines have also been shown to induce cytotoxic activity in 
neutrophils (Kang et al., 1998).  However the eye and testis may be protected from 
this neutrophilic infiltration due to the presence of transforming growth factor-β 
(TGF-β) in their cellular microenvironment (Chen et al., 1998). 
Neutrophils have been shown to express Fas and anti-Fas antibody accelerates their 
apoptosis (Iwai et al., 1994).  Initially they were shown to express FasL and release 
sFasL which was able to induce death in activated Jurkat cells (Liles et al., 1996).  
Furthermore blocking the Fas receptor, partially suppressed spontaneous neutrophil 
apoptosis suggesting that Fas/FasL may mediate neutrophil apoptosis by both an 
autocrine and paracrine pathway (Liles et al., 1996).  Fas-mediated induction of 
neutrophil apoptosis might therefore accelerate their clearance from sites of 
inflammation. At such sites cytokines and inflammatory mediators including GM-
CSF, LPS and complement factor C5a are known to prolong neutrophil survival 
(Haslett, 1997; Ward et al., 1999). 
1.5 The Macrophage 
Macrophages, large mononuclear phagocytes found in tissues, were first described 
by Elie Metchnikoff over 100 years ago (Karnovsky, 1981).  They originate in the 
bone marrow, move into the bloodstream as monocytes and finally into the tissues 
where they differentiate into macrophages (Territo and Cline, 1975).  Macrophages 
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function in the innate immune system primarily as phagocytes, phagocytosing not 
only airborne particulates that reach alveoli but also microorganisms. 
The macrophage has signalling pattern recognition receptors that respond to 
pathogen-associated molecular patterns e.g. mammalian Toll-like receptors (TLRs) 
that recognise bacterial lipopolysaccharide (LPS), viral double-stranded RNA, 
unmethylated CpG dinucleotides (common in bacterial DNA), mannans of yeast, 
glycolipids of mycobacteria, lipoproteins of bacteria and parasites and lipoteichoic 
acids of Gram-positive bacteria.  LPS is initially bound by lipopolysaccharide-
binding protein (LBP) and this complex binds to the membrane-anchored protein, 
CD14.  CD14 has no cytoplasmic domain and requires TLR4 for transduction of the 
LPS signal.  TLR4 activates nuclear factor-κB (NF-κB) and stimulates the 
expression of chemokines and cytokines, important in mediating inflammatory 
responses, including, interleukin-8 (IL-8), leukotriene B4 (LTB4), interleukin-1 and 
tumour necrosis factor-α (TNF-α) (Palsson-McDermott and O'Neill, 2004).  
Endocytic pattern recognition receptors are also found on the surface of macrophages 
and include the macrophage mannose receptor and the macrophage scavenger 
receptor.  These receptors enhance phagocytosis of microorganisms by the 
macrophage.  Phagocytosed bacterial antigens are then processed intracellularly and 
presented by these professional antigen-presenting cells to the adaptive immune 
system.  However macrophages also phagocytose apoptotic neutrophils and are 
therefore important in the resolution of inflammation (diagram 3.1). 
1.5.1 Alveolar macrophages 
Macrophages become highly specialized and specifically adapt to 
microenvironments.  In the lung, macrophages are exposed to inhaled microbes, 
toxic substances and fine particulate matter.  They must remain in a quiescent state in 
response to harmless antigens but be able to become activated in response to 
infectious microbes.  Alveolar macrophages, in their quiescent state, do not produce 
inflammatory cytokines and downregulate expression of the phagocytic receptor 
CD11b such that they display poor phagocytic activity (Holt, 1978).  Their 
importance in maintaining a tonic state was elegantly demonstrated when alveolar 
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macrophages were eliminated in vivo using clodronate-filled liposomes, this led to 
overt inflammatory reactions in response to harmless particulate and soluble antigens 
(Thepen et al., 1989).  Furthermore, when alveolar macrophages were mixed with 
dendritic cells in vitro, they suppressed T-cell activation through release of 
prostaglandins, interleukin-10 (IL-10) and transforming growth factor-β (TGF-β) 
(Holt, 1993).   
In animal models of ALI, it has been shown that the rapid recruitment of neutrophils 
and later recruitment of blood monocytes to the lung is dependent on resident 
alveolar macrophages (Maus et al., 2002).  In response to intratracheal monocyte 
chemoattractant, the recruitment of alveolar monocytes was largely dependent on the 
β2 integrin CD11b/CD18 and CD54 as well as the β1 integrin CD49d while the co-
administration of intratracheal monocyte chemoattractant and LPS resulted in 
amplified monocyte recruitment dependent additionally on CD11a and CD106 (Maus 
et al., 2002).   
The lung microenvironment itself determines the macrophage phenotype.  The 
breakthrough in our understanding of this process came when it was shown that αvβ6 
integrin-deficient mice had activated alveolar macrophages due to a lack of TGF-β 
activation (Morris et al., 2003).  The αvβ6 integrin can activate latent TGF-β by 
binding to the latency-associated peptide, an N-terminal inactivating fragment of 
TGF-β.  This knowledge has recently been expanded.  Alveolar macrophages, in the 
quiescent state closely adhere to alveolar epithelial cells which induces expression of 
the αvβ6 integrin on the epithelial cells.  This leads to local activation of TGF-β 
which in turn binds to its receptor expressed on macrophages, inducing 
phosphorylation of SMAD-2 and -3 thereby suppressing macrophage phagocytosis 
and cytokine production.  When alveolar macrophages are exposed to infectious 
agents such as LPS, signalling through their Toll-like receptors leads to a rapid loss 
of contact with the alveolar epithelial cells, downregulation of αvβ6 integrin 
expression on the epithelial cells, loss of activation of TGF-β and priming of the 
macrophage to secrete pro-inflammatory cytokines (Takabayshi et al., 2006). 
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During the inflammatory process, as discussed earlier, monocytes are recruited to the 
alveolar space and these cells have an inflammatory phenotype (Warmington et al., 
1999).  It takes a few days before these cells acquire the suppressive phenotype of 
alveolar macrophages (Bilyk and Holt, 1995).  Recently the mechanism by which 
macrophages switch back to their suppressive phenotype after exposure to infectious 
agents was further elucidated; a few days after exposure to the infectious agent, 
lymphocytes secreting interferon-γ (IFN-γ) stimulated the production of matrix 
metalloproteinase-9 (MMP-9) by the alveolar macrophages.  MMP-9 can activate 
latent TGF-β and by the mechanism described above, this switches the macrophage 
back to its anti-inflammatory phenotype (Takabayshi et al., 2006). 
An elegant proteomic study has shown differential protein expression between 
human alveolar macrophages and their precursor blood monocytes which reflect their 
different phenotypes (Wu et al., 2005). 
1.6 The Macrophage, the Neutrophil and Inflammation 
At a cellular level, the processes involved in the resolution of inflammation have 
been further elucidated.  Neutrophils produce prostaglandins and leukotrienes from 
arachadonic acid (diagram 4.1.).  During neutrophil activation, the NF-κB signalling 
pathway induces transcription of genes encoding enzymes which switch the 
production of arachidonic acid metabolites to lipoxins (Levy et al., 2001).  Lipoxins 
are known to slow the entry of neutrophils to inflamed sites, reduce vascular 
permeability and stimulate macrophage phagocytosis of apoptotic neutrophils 
(Serhan et al., 1995; Takano et al., 1998; Godson et al., 2000).  Recently other 
groups of anti-inflammatory lipid mediators have been identified, including resolvins 
and protectins, which are metabolites of omega-3 polyunsaturated fatty acids (Serhan 
et al., 2002; Hong et al., 2003; Marcheselli et al., 2003). 
The ageing inflammatory neutrophil, as discussed previously, usually dies by 
apoptosis.  The macrophage recognizes several surface receptors on the apoptotic 
cell, including phosphatidylserine, the integrin αvβ3 and CD36, resulting in 
phagocytosis (Savill et al., 1989; Hart et al., 1996; Fadok et al., 1998).  In so doing, 
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the macrophage itself, switches to an anti-inflammatory phenotype (Fadok et al., 
1998).  Macrophages are themselves cleared from inflamed sites by the draining 
lymphatics (Bellingan et al., 1996). 
The Fas-FasL pathway may also be important in the interaction between 
macrophages and neutrophils at inflamed sites.  Macrophages express FasL and 
sFasL has been identified in the conditioned supernatants of activated macrophages 
(Brown & Savill, 1999).  The conditioned supernatants containing sFasL accelerated 
neutrophil apoptosis but other factors were also present which contributed to the 
observed induction of neutrophil apoptosis (Brown & Savill, 1999).  The nature of 
these factors will be explored further. 
1.7 Aims of this project 
Neutrophilic inflammation in the alveoli is the hallmark of acute lung injury 
(ALI)/adult respiratory distress syndrome (ARDS).  In early ARDS, bronchoalveolar 
lavage fluid (BALF) delays neutrophil apoptosis but this is largely due to 
granulocyte- colony stimulating factor (G-CSF) and granulocyte/macrophage - 
colony stimulating factor (GM-CSF) (Matute-Bello et al., 1997).  However in late 
ARDS, our group showed that BALF accelerated neutrophil apoptosis (Donnelly & 
Haslett, unpublished observation).   BALF from patients with ARDS has also been 
shown to contain soluble FasL (sFasL) (Matute-Bello et al., 1999).  The Fas/FasL 
pathway is important in cellular apoptosis and it is therefore proposed that Fas-
mediated induction of neutrophil apoptosis will accelerate resolution of inflammation 
by apoptotic clearance of neutrophils from the lung and their subsequent macrophage 
phagocytosis.  The role of this death pathway in regulating neutrophil longevity as 
well as the effect of the inflammatory milieu will be explored.  As 
sepsis/endoxaemia is the leading cause of ALI/ARDS in humans, the role of the 
LPS-activated macrophage in control of neutrophil longevity and the importance of 
the Fas/FasL pathway in this regard will be determined.  Thus, the role of Fas/FasL, 
inflammatory mediators and LPS-stimulated macrophages on human neutrophil 





Figure 1.1. The alveolus in normal l.ung and ARDS. 
In ARDS (right-hand side) there is damage to the bronchial and alveolar epithelium 
and pulmonary endothelium.  A hyaline membrane has formed next to the denuded 
membrane.  As a result of the leaky blood-air barrier, there is a protein-rich exudate 
in the alveolus.  Neutrophils have adhered to the damaged endothelium and activated 
neutrophils have transmigrated into the alveolus where they are producing 
inflammatory mediators.  The alveolar macrophage has been activated by 
macrophage inhibitory factor (MIF) to secrete cytokines (TNF-α, IL-1, IL-6, IL-8 
and IL-10) that are important in regulating the inflammatory response. 









Unless otherwise stated, all chemicals were obtained from Sigma, Poole, UK.  All 
tissue culture reagents were purchased from Life Technologies, Paisley, UK. 
2.1.2 Antibodies and Pharmacological Inhibitors 
The antibodies used in this study are detailed in table 2.1.  The pharmacological 
inhibitors used in this study are detailed in table 2.2. 
2.2 Cell Biology Techniques 
2.2.1 Neutrophil and monocyte isolation from human peripheral blood  
Human polymorphonuclear leukocytes and mononuclear leukocytes were isolated 
from peripheral human blood (80-320ml) taken from healthy donors as previously 
described by Haslett et al., (1985).  This technique was carried out under sterile 
conditions using endotoxin-free reagents and tissue culture plastics to prevent 
inappropriate cell activation.  Unless otherwise stated it was carried out at room 
temperature.  The blood was citrated (0.38%) (Phoenix pharmaceuticals) to prevent 
clotting, mixed by gentle inversion and centrifuged (Sanyo Mistral 3000i centrifuge) 
for 20 minutes at 220G with zero brake.  Centrifugation separates the blood into a 
lower dense cellular layer, the packed cell volume (PCV), which constitutes 
approximately 45% of the circulating blood volume and contains the red blood cells, 
above which there is the buffy coat, rich in leukocytes, and the supernatant which is 
platelet-rich plasma (PRP).  The supernatant was carefully removed and 10ml of PRP 
was added to glass bottles with 220µl 1M calcium chloride.  At 37°C, the calcium 
activates the platelets to form a platelet plug and thus autologous serum was 
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obtained.  Dextran sedimentation of the packed cell volume (6ml of 6% dextran and 
19ml 0.9% (w/v) saline were added to the PCV), separated the residual red cells and 
leukocytes.  After 30 minutes at room temperature, the upper leukocyte rich layer 
was removed and washed at 220G for 6 minutes. 
The neutrophils/eosinophils and mononuclear cells were separated by centrifugation 
through discontinuous isotonic Percoll gradients (55/68/81%) at 700g for 20 minutes 
with zero brake.  The mononuclear cells were isolated from the 55/68% interface and 
washed twice in phosphate buffered saline (PBS) without cations before being 
resuspended at 4x106/ml in Iscoves modified Dulbeccos medium (IMDM) 
(GIBCO) containing 20IU/ml penicillin/streptomycin.  Monocytes were enriched by 
selective adherence to tissue culture plastic, a method previously demonstrated by 
Ackerman and Douglas (1978).  Non-adherent lymphocytes were removed by 
aspiration and the wells washed twice with Hanks balanced salt solution (HBSS).  
Over a period of 5 days, when the adherent monocytes were cultured in IMDM 
containing 10% autologous serum, they differentiated into mature monocyte-derived 
macrophages (figure 2.1b).  As autologous serum contains variable cytokines, the 
adherent monocytes were also differentiated in serum-free media with 250U/ml 
recombinant human GM-CSF (R&D Systems) (Vincent et al., 1992).  The 
neutrophils were isolated from the 68/81% interface and washed twice in phosphate 
buffered saline (PBS) without cations.  The purity of the neutrophils was greater than 
97% as assessed by forward/side scatter analysis on a EPICS Coulter flow cytometer 
(purity of granulocyte population) and by morphology (figure 2.1a).  Cytospins of 
harvested cells were stained with Diff Quik and a minimum of 500 cells per slide 
were counted. 
2.2.2 Assessment of apoptosis and necrosis 
Apoptosis was assessed quantitatively by assessment of morphology and the 
differential binding of Annexin V to apoptotic cells.  Cytospins were prepared in 
duplicate or triplicate for each experimental condition; 120µl of cells centrifuged at 
300G onto glass slides, fixed in methanol and stained with Diff-Quik (Gamidor, 
Abingdon, UK).  Cells were counted using oil immersion microscopy (x100 
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objective lens) to determine the proportion of cells with distinctive apoptotic 
morphology i.e. cell shrinkage, nuclear condensation (figure 2.2a).  A minimum of 
500 cells/slide were counted and the results were expressed as the mean + SEM. 
Annexin V binds to phosphaditylserine exposed on the surface of apoptotic cells.  
Fluorescein isothiocyanate (FITC)-labelled recombinant human Annexin V (Bender 
Medsystems, Vienna, Austria) was diluted (1:200) in binding buffer and 180µl was 
added to 20µl of cells (5x106/ml) (in duplicate or triplicate) and incubated at 4°C for 
10 minutes before flow cytometric analysis on EPICS XL2 (figure 2.2b).  This is a 
previously validated method of assessment of apoptosis (Majewska et al., 2000; 
Vermes et al., 2000).  In the assessment of apoptosis using Annexin V, we used cells 
which had not undergone apoptosis as a negative control however other groups have 
used an EDTA control to indicate the calcium-dependent specific binding of Annexin 
V (Boas et al., 1998; Cederholm et al., 2005).  Necrosis was determined by assessing 
the integrity of cells (at least 500) by virtue of their exclusion of the vital dye trypan 
blue. 
Apoptotic rates assessed by morphology and Annexin V binding were highly 
correlated (n=12, r = 0.93, p<0.0001, data not shown). 
2.2.3 Cell Culture  
All cell culture was carried out with aseptic technique within a tissue culture hood 
(Envair Class II) and cultures were maintained in an incubator at 37°C/5% CO2.  
Heat-inactivated serum was prepared by heating serum at 56°C for 60 minutes. 
2.2.3.1 A549 cells 
A549 cells are derived from a human lung carcinoma (ECACC ref. 86012804).  
Media for use with the A549 cells was Dulbeccos modified Eagles medium 
(DMEM) supplemented with 10% heat-inactivated foetal bovine serum (FBS), 2mM 
glutamine and 20IU/ml penicillin/streptomycin.  The cells were adherent and cultures 
were split (1:6) on reaching 70-90% confluency (approximately every 3 days) using 
trypsin (0.05% w/v)/ethylenediaminetetraacetic acid (EDTA) (0.02% w/v).  The 
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clones stably transfected with FasL were a kind gift from Dr Shirley ODeas (MRC 
Centre for Inflammation). 
2.2.3.2 Jurkat E6.1 cells 
Jurkat cells are a human leukaemic T cell lymphoblastic cell line (ECACC ref. 
88042803). Media for the Jurkat T cell line was RPMI 1640 supplemented with 10% 
heat-inactivated FBS, 2mM glutamine and 20IU/ml penicillin/streptomycin.  The 
cells grew in suspension and cultures were maintained between 3-9 x 105/ml. 
2.2.3.3 K562/KFL9 cells 
The K562 cell line (ECACC ref. 89121407) was established from a pleural effusion 
of a patient with chronic myelogenous leukaemia in terminal blast crisis.  Media for 
the K562/KFL9 cell line was RPMI 1640 supplemented with 10% heat-inactivated 
FBS, 2mM glutamine and 20IU/ml penicillin/streptomycin.  The cells grew in 
suspension and cultures were maintained between 1-10 x 105/ml.  K562 cells stably 
transfected with FasL (KFL9) were a kind gift from Dr D. Kaplan (Case Western 
Reserve University, Cleveland, USA) to Dr Simon Brown (MRC Centre for 
Inflammation). 
2.2.3.4 THP-1 cells 
The THP-1 cell line (ECACC ref. 88081201) was established from the peripheral 
blood of a patient with acute monocytic leukaemia.  Media for the THP-1 cell line 
was RPMI 1640 supplemented with 10% heat-inactivated FBS, 2mM glutamine and 
20IU/ml penicillin/streptomycin.  The cells grew in suspension and cultures were 
maintained between 2-9 x 105/ml. 
2.2.4 The effect of inflammatory mediators on constitutive and Fas-induced 
neutrophil apoptosis and investigation of their signalling pathways using 
pharmacological inhibitors  
Freshly isolated neutrophils (5x106/ml) were initially cultured in IMDM with 10% 
autologous serum (AS) or 10% FBS or phosphate buffered saline (PBS).  The 
neutrophils were incubated in 96 flat-bottomed plastic flexi-well plates (Costar) with 
activating anti-Fas antibody (CH-11) (Upstate Cell Signalling Solutions, USA) and 
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recombinant FasL (SUPERFasL) (Alexis Biochemicals Corporation, USA) at 
varying concentrations for 3 hours and apoptosis assessed by morphology (n=2) and 
Annexin V binding (n=2).  Jurkat cells were used as a positive control as Fas 
stimulation is known to accelerate their apoptosis.  The neutrophils were also pre-
incubated for 1 hour in a shaking water bath with the poly-caspase inhibitor zVAD 
(100µM) (Calbiochem, UK) the agonistic anti-Fas antibody, ZB4 (500ng/ml) 
(Upstate Cell Signalling Solutions, USA) and the neutralising anti-FasL antibody 
NOK-1 (500ng/ml) (BD Biosciences, USA) prior to being plated out in 96 flat-
bottomed plastic (Costar) flexi-well plates with CH-11 (500ng/ml) for 3 hours.  
Apoptosis was assessed by morphology (n=2) and Annexin V binding (n=2). 
To assess the effect of inflammatory mediators, the freshly isolated neutrophils 
(5x106/ml) in PBS and 10% FBS were pre-incubated for 1 hour in a shaking water 
bath with LPS (0.1µg/ml) (E.coli 0127:B8, Sigma), fMLP (10nM) (Calbiochem) and 
GM-CSF (50U/ml) (R&D Systems) prior to being plated out in 96 flat-bottomed 
plastic flexi-well plates (Costar) with CH-11 (500ng/ml).  Apoptosis was assessed by 
morphology (n=2) and Annexin V binding (n=2) after a further 3 hours incubation. 
The different intracellular signalling pathways were assessed by pre-incubating the 
freshly isolated neutrophils for 1 hour in a shaking water bath with various 
pharmacological inhibitors prior to being plated out in 96 flat-bottomed flexi-well 
plates with CH-11 (500ng/ml) and apoptosis assessed as above. 
2.2.5 THP-1, transfer of conditioned media and its effect on human neutrophil 
apoptosis 
THP-1 cells (1x106/ml), in media as above, were activated with phorbol 12-myrisate 
13-acetate (PMA) (25ng/ml) and incubated on fibronectin-coated plates overnight.  
The cells were then washed and incubated in fresh media for a further 24 hours.  The 
differentiated THP-1 cells were then stimulated with LPS (1µg/ml) for varying time 
periods before being co-incubated with fresh neutrophils (2x106/ml) for 4 hours or 
their conditioned media being transferred to fresh neutrophils (2x106/ml) and 
incubated for 4 hours. 
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2.2.6 Human monocyte-derived macrophages, transfer of conditioned media 
and its effect on human neutrophil apoptosis 
The human monocyte-derived macrophages were differentiated for 5 days in either 
IMDM and 10% autologous serum or serum-free media supplemented with 250U/ml 
recombinant human GM-CSF (R&D Systems) before stimulation with 1µg/ml LPS 
(E.coli 0127:B8, Sigma) for the appropriate time.  The serum-free macrophages also 
required purified human lipopolysaccharide binding protein (found constitutively in 
serum) (Hycult Biotechnology, MA, USA). 
The conditioned supernatants were centrifuged at 300G for 5 minutes and then ultra 
centrifuged at 100 000G for 10 minutes before transfer to freshly isolated neutrophils 
at 2x106/ml and incubated for the appropriate time.  In some experiments, the 
conditioned media was further fractionated through Centricon 50kD filters according 
to the manufacturers instructions.  The freshly isolated neutrophils (5x106/ml) were 
also pre-incubated with an anti-TNF-α antibody (3µg/ml) (R&D Systems, USA) and 
antagonistic anti-Fas antibody (ZB4, 500ng/ml) (Upstate Cell Signalling Solutions, 
USA) for 1 hour in a shaking water bath before incubation with the conditioned 
media.  In addition, the conditioned media was itself heat-inactivated at 56°C for 1 
hour. 
In the experiments requiring apoptotic neutrophils, on day 4 of macrophage 
differentiation, fresh neutrophils (5x106/ml) were incubated overnight in 50ml tissue 
culture flasks and apoptosis assessed by morphology.  Macrophages were co-
incubated with the apoptotic neutrophils for 4 hours at 37°C.  For cytokine analysis 
and two-dimensional gel electrophoresis, the conditioned supernatant was stored at -
70°C. 
2.3 Biochemical assays and methods  
2.3.1 Receptor surface expression assessed using flow cytometry 
Flow buffer was prepared by adding 0.1% (w/v) azide and 0.2% (w/v) bovine serum 
albumin to 500ml phosphate buffered saline without cations.  Cells, 100µl 
(5x105/ml), were plated onto 96 well round-bottomed plastic flexi-well plates 
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(Costar) and centrifuged (200G) for 2 minutes at 4°C.  All subsequent steps were 
carried out at 4°C.  The supernatant was discarded and the cells resuspended by 
gentle vortexing.  Rabbit immunoglobulin, 10µl (1:20), was added for 5 minutes to 
block immunoglobulin receptors.  The plates were again centrifuged, the supernatant 
discarded and cells resuspended by gentle vortexing.  The primary antibody was 
appropriately diluted in flow buffer and added to the resuspended cells for 30 
minutes before washing off the non-bound antibody (twice).  The secondary FITC/ 
phycoerythrin (PE)-conjugated antibody was appropriately diluted and added to the 
resuspended cells for 30 minutes before washing off the non-bound antibody (twice).  
The cells were then resuspended in 200µl flow buffer and binding was assessed by 
flow cytometry. 
2.3.2 Preparation of cell lysates for Western blotting 
Lysates were prepared at 4°C.  Cells in suspension were pelleted by centrifugation 
and the supernatant discarded.  To minimize problems with proteolysis, lysates were 
prepared by methods normally used for electrophoretic mobility shift assay (EMSA) 
preparation (Ward et al., 1999).  The cell pellet was resuspended in 100µl lysis 
buffer (buffer A (10mM Tris-HCL, pH 7.8, 1.5mM EDTA, 10mM KCL), 0.5mM 
dithiothreitol, 1µg/ml aprotinin, leupeptin and pepstatin A, 1µM 4-(2-aminoethyl) 
benzenesulphonyl fluoride, 1mM sodium orthovanadate, 0.5mM benzamidine and 
2mM levamisole) and placed on ice for 10 minutes.  Following the addition of 0.1 
volumes of 10% Nonidet P-40 (w/v), the cells were vortexed briefly and centrifuged 
at 12000G for 2 minutes at 4°C.  The supernatants were transferred to clean 
Eppendorfs and the nuclear pellet discarded.  The protein content of the supernatants 
was estimated as below and the appropriate volume of 6x sample buffer (0.375M 
Tris-HCL, pH 6.8, 12% sodium dodecyl sulphate (SDS), 15% β-mercaptoethanol, 
40% glycerol and 0.03% bromophenol blue) was added to the supernatants prior to 




2.3.3 Protein estimation 
The protein concentration of lysates was estimated using the Pierce protein assay 
system which is based on the Bradford Coomassie brilliant blue dye binding system.  
A range of bovine serum albumin standards was used to construct a standard curve 
using spectrophotometry and protein samples were diluted to fall within the linear 
range of this curve.  Protein concentrations of all samples were routinely measured in 
duplicate. 
2.3.4 Polyacrylamide gel electrophoresis 
A Bio-Rad mini trans-blot module (Protean II) was used.  In order to maximize 
resolution of the protein of interest, the appropriate percentage sodium dodecyl 
sulphate polyacrylamide gel electrophoresis (SDS-PAGE) separating gel was used.  
The appropriate quantity of 30% acrylamide/bis-acrylamide was added to the 
separating buffer (e.g. 20ml of 9% separating gel solution required 8.82ml of 
deionised water, 6ml of 30% acrylamide/bis-acrylamide , 5ml of 1.5M Tris base pH 
8.8, 0.08ml of 20% SDS, 0.08ml of 10% ammonium persulphate and 20ul TEMED).  
A 3% stacking gel solution was also prepared (for a final volume of 8ml, 5.51ml of 
deionised water, 0.8ml of 30% acrylamide/bis-acrylamide, 1ml of 0.5M Tris base, 
pH 6.8, 0.08ml of 10% SDS, 0.6ml of 12% ammonium persulphate and 8µl of 
TEMED were required) (Laemmli, 1970).  Standardised amounts of protein for each 
sample were loaded and the proteins resolved by electrophoresis at 150V. (The 
electrophoresis buffer was 250mM Tris/1.92M glycine (pH 8.3) and 0.1% SDS) 
2.3.5 Immunoblotting 
Proteins resolved by polyacrylamide gel electrophoresis were transferred to 
nitrocellulose membranes at 80V for 1 hour.  (The transfer buffer was 250mM 
Tris/1.92M glycine (pH 8.3) and 20% methanol).  Transfer efficiency and equality of 
loading were assessed by staining membranes with Ponceau S solution for 3 minutes 
followed by washing with distilled water.  Ponceau S was removed by washing with 
Tris buffered saline (TBS) (20mM Tris-HCl, pH 7.6, 136mM sodium chloride) 
containing 0.1% (v/v) Tween 20 (TBST). 
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The nitrocellulose membranes were then blocked in TBST with 5% (w/v) non-fat 
powdered milk (Marvel) for a minimum of 1 hour at room temperature.  Blots were 
incubated with primary antibodies at the recommended concentration in TBST or 
TBS with 1% (w/v) bovine serum albumen, overnight at 4°C.  Three washes of 10 
minutes each using TBST were then carried out prior to incubation with the 
appropriate horseradish peroxidase conjugated secondary antibody for 1 hour in 
TBST at room temperature.  Blots were washed with three washes of 10 minutes 
each using TBST prior to developing.  Protein bands were visualised by enhanced 
chemoluminescence (Amersham) and autoradiography. 
2.3.6 Re-probing with anti - β-actin antibody 
The immunoblots were stripped in buffer (62.5mM Tris base (pH 6.7), 0.075% β-
mercaptoethanol and 2% SDS) for 1 hour at 50°C.  Three washes of 10 minutes each 
using TBST were then carried out prior to blocking in TBST with 5% (w/v) non-fat 
powdered milk (Marvel) for a minimum of 1 hour at room temperature.  The blots 
were then incubated with 1:50 anti - β-actin antibody for 1 hour at room temperature.  
Three further washes of 10 minutes each using TBST were then carried out prior to 
incubation with 1:2000 horseradish peroxidase conjugated goat anti-mouse antibody 
for 1 hour in TBST at room temperature.  The blots were then washed and developed 
as above.  
2.3.7 Two-dimensional gel electrophoresis 
ExcelGel SDS gradient 8-18, ExcelGel buffer strips (Pharmacia Biotech), a 
Multiphor II electrophoresis unit and a MultiTemp II thermostatic circulator were 
used in these experiments which were carried out in duplicate.  The samples were 
dissolved in reducing SDS sample buffer and denatured as previously described.  
Light paraffin oil (1ml) was used as insulating fluid and placed on the thermostatic 
circulator at 15°C before the gel was placed on the cooling plate so that the polarity 
of the gel corresponded to that of the plate.  The cathodic and anodic buffer strips 
were applied to their respective sides of the gel.  The applicator strip was placed 
5mm from the cathodic buffer strip and 20ul of sample applied. 
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Electrophoresis was commenced at 300V, 2mA for 1 minute and gradually increased 
over the next 30 minutes to 3500V which was maintained for approximately 2 hours 
until the Bromophenol Blue front had reached the anode.  The gel was immediately 
fixed (40% ethanol, 10% acetic acid) for 30 minutes and incubated overnight at room 
temperature (250ml of incubation solution contained 75ml ethanol, 17g sodium 
acetate·3H2O, 1.3ml glutaraldehyde (25% w/v) 0.5g sodium thiosulphate and 
distilled water).  The gel was washed for 5 minutes, three times, in distilled water.  
The gel was stained for 40 minutes in silver solution (250ml contained 0.25g silver 
nitrate, 50µl formaldehyde and distilled water).  The protein bands were developed in 
developing solution (250ml contained 6.25g sodium carbonate, 25µl formaldehyde 
and distilled water) for approximately 15 minutes before stopping the reaction (  with 
3.65g EDTA-Na2·2 H2O in 250ml distilled water for 10 minutes.  The gel was 
washed for 5 minutes, three times, in distilled water and preserved in 10% glycerol. 
 
2.3.8 Quantitative analysis of inflammatory cytokines in cell supernatants 
using a flow cytometric bead array 
The bead array was purchased from Becton Dickinson (BD) and measured IL-8, IL-
1β, interleukin-6 (IL-6), interleukin-10 (IL-10) and TNF-α.  Initially the cytokine 
standards were reconstituted and diluted appropriately.  The standard curve covered 
concentrations from 20-5000pg/ml.  The capture beads for each cytokine are in 
individual bottles and were pooled at the start of the experiment.  To each assay tube, 
50µl of mixed capture beads, 50µl of PE detection reagent and 50µl of either a 
standard or test sample were added.  The samples were then incubated at room 
temperature, protected from light, for 3 hours.  The samples were then washed with 
1ml wash buffer and centrifuged at 200G for 5 minutes.  The supernatants were 
carefully removed and discarded and the cytokine beads resuspended in 300µl of 
wash buffer before being analysed on the BD flow cytometer.  
Chapter 2 
 32
2.4 Molecular Biology 
2.4.1 RNA isolation 
Cells (5x106/ml) were pelleted and resuspended in 1ml Tri reagent (Sigma).  
Chloroform (0.2ml) was added, the samples shaken vigorously for 15 seconds and 
allowed to stand for 5 minutes at room temperature.  The samples were then 
centrifuged at 12000G for 15 minutes at 4°C which separated the mixture into three 
phases; a red organic phase containing protein, interphase containing DNA and 
colourless upper phase containing RNA.  The aqueous phase was transferred to a 
fresh RNase-treated tube to which 0.5ml of isopropanol was added and allowed to 
stand for 5 minutes at room temperature.  The samples were then centrifuged at 
12000G for 10 minutes at 4°C.  The RNA pellet was washed with 1ml 75% ethanol 
and centrifuged at 7500G for 5 minutes at 4°C.  The RNA pellet was air dried and 
50µl formamide water added.  The quantity of RNA was measured on a 
spectrophotometer. 
2.4.2 First strand cDNA synthesis 
First strand cDNA synthesis was performed using a Superscript first strand synthesis 
system (Life Technologies).  RNA (0.5µg) was incubated with 1µl RNase inhibitor, 
1µl oligo dT (0.5µg/ml), and diethylpyrocarbonate (DEPC)-treated water (added to a 
final volume of 11 µl) at 70°C for 10 minutes.  Reaction mixture containing 10x 
reverse transcription buffer (2 µl), 0.1M DTT (2µl) and 25mM magnesium chloride 
(4 µl) were added and incubated at 42°C for 2 minutes.  Superscript II (1 µl) was 
added and gently mixed before the reverse transcription reaction was allowed to 
proceed at 42°C for 60 minutes before termination by heating to 70°C for 10 
minutes.  The cDNA was stored at -20°C until required. 
2.4.3 Purification of plasmid DNA 
The cDNA of the Fas receptor (GenBank: NM_000043) in the pCMV-SPORT6 
plasmid (GenBank: BC012479, ATCC: MGC-21432) was purchased from LGC 
Promochem, UK.  The freeze-dried colonies were initially grown in 1ml LB (Luria-
Bertani) with 50µg/ml ampicillin for 5 hours at 37°C with continuous shaking before 
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being added to 4ml LB with 50µg/ml ampicillin and grown overnight at 37°C with 
continuous shaking. 
DNA was purified using the QIAprep Miniprep system (Qiagen, Crawley).  The cells 
in 2ml bacterial culture were pelleted, the supernatant discarded and the cells 
resuspended in buffer P1 (250µl) containing RNase A.  Buffer P2 (250µl) was then 
added to lyse the bacteria under alkaline conditions and gently inverted 4-6 times to 
mix.  Lastly buffer N3 (350µl) was added to neutralise and adjust to high-salt binding 
conditions in one step.  The tube was gently inverted to mix and then centrifuged at 
13 000rpm for 10 minutes and the supernatant carefully transferred to the Qiaprep 
column.  The column was centrifuged at 13 000rpm for 1 minute and the flow-
through discarded.  The column was then washed with 0.75ml buffer PE and 
centrifuged for 1 minute.  The flow-through was again discarded before centrifuging 
for an additional 1 minute.  The DNA was eluted by adding 50µl buffer EB (10mM 
Tris·Cl, pH 8.5) and standing for 1 minute before centrifuging for 1 minute.  A 
Qiagen Plasmid Maxi kit was used for the purification of larger quantities of the 
plasmid DNA.  100µl of the bacterial broth was grown in 100ml volumes overnight.  
The cells were then pelleted by centrifugation at 6000G for 15 minutes at 4°C and 
resuspended in 4ml buffer P1. Buffer P2 (4ml) was added to lyse the bacteria , gently 
mixed and incubated at room temperature for 5 minutes.  Chilled buffer P3 was 
added (4ml), gently mixed, incubated for 15 minutes at 4°C and centrifuged at 
20000G for 30 minutes at 4°C.  The supernatant was removed and re- centrifuged at 
20000G for 30 minutes at 4°C.  A Qiagen-tip 100 was equilibrated by applying 4ml 
buffer QBT and allowing the column to empty by gravity.  The supernatant was 
applied to the column and allowed to enter the resin by gravity flow.  The Qiagen-tip 
was washed twice with 10ml buffer QC.  The DNA was then eluted with 5ml buffer 
QF and the DNA precipitated by adding 3.5ml isopropanol and centrifuging at 
15000G for 30 minutes at 4°C.  The DNA pellet was washed with 2ml 70% ethanol, 
centrifuged at 15000G for 10 minutes, allowed to air dry and dissolved in 10mM 
Tris·Cl, pH 8.5.  The DNA was quantified and assessed using spectrophotometry and 
agarose gel electrophoresis. 
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2.4.4 Polymerase chain reaction 
Mastermix (for FasL cytoplasmic tail) (total volume 50µl) containing 10x 
polymerase chain reaction (PCR) buffer (5µl) 50mM magnesium chloride (1.5µl), 
dNTP mix (final concentration 125µM of each dNTP) and forward and reverse 
primers (final concentration of each 500nM) was prepared and added to each 0.5ml 
Eppendorf tube.  For FasL, the forward primer was 5-GGA TTG GGC CTG GGG 
ATG TTT CA-3 and the reverse primer 5-TAA TAC GAC TCA CTA TAG GGT 
TGT GGC TCA GGG GCA GGT TGT TG-3giving a product of 343kB.  For human 
GAPDH the forward primer was 5-TGC CTC CTG CAC CAC CAA CTG C-3 and 
the reverse primer 5-AAT GCC AGC CCC AGC GTC AAA G-3 giving a product 
of 456kB.  For the Fas cytoplasmic tail, the primers are shown in diagram 4.5b.  
Template cDNA (10ng/50µl) or distilled water as control was added prior to the 
addition of 1.25 units of the enzyme Taq DNA polymerase (GIBCO).  The following 
thermal cycling profiles were used.  For FasL and GAPDH, samples were denatured 
at 94°C for 3 minutes, then 35 cycles of: denaturation at 94°C for 45 seconds, primer 
annealing at 63°C for 30 seconds and DNA extension at 72°C for 1.5 minutes.  A 
final extension at 72°C was performed for 10 minutes.  For the Fas cytoplasmic tail, 
samples were denatured at 94°C for 2.5 minutes, then 25 cycles of: denaturation at 
94°C for 30 seconds, primer annealing at 51°C for 30 seconds and DNA extension at 
72°C for 40 seconds.  A final extension at 72°C was performed for 5 minutes.  
Oligonucleotide primers were synthesized by MWG-Biotech, Ebersberg, Germany.  
2.4.5 Agarose gel electrophoresis of DNA 
DNA samples were mixed with 6x blue loading buffer and run on 1% agarose gels 
with Tris-borate electrophoresis (TBE) buffer and ethidium bromide (2µl in 50ml) at 
100V for 30 minutes.  The bands were visualised on an ultraviolet transilluminator 
and images recorded on Polaroid film. 
2.4.6 Gel extraction and purification of DNA 
DNA extraction from agarose was performed using a QIAquick Gel Extraction kit 
(Qiagen, Crawley, UK).  The DNA fragment was excised from the agarose gel using 
a clean scapel blade and placed in an Eppendorf tube.  The fragment was then 
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incubated at 50°C for 10 minutes in buffer QG to dissolve the agarose.  Isopropanol 
(100µl) was added and each sample placed in a spin column.  DNA was applied to 
the membrane by centrifugation for 1 minute at 13000rpm in a microfuge.  The flow-
through was discarded and the membrane washed with 750µl of buffer PE before 
further centrifugation for 1 minute at 13000rpm.  The flow-through was again 
discarded and the column centrifuged to remove all traces of wash buffer.  The 
column was then placed in a clean Eppendorf tube and the bound DNA eluted by the 
addition of 50µl buffer EB followed by centrifugation at 13000rpm for 1 minute. 
2.4.7 Subcloning of DNA 
The PinpointTM Xa-1 T-Vector system (Promega, Madison, WI, USA) was used to 
subclone the DNA product into the PinpointTM Xa vector.  The PinpointTM Xa vector 
contains a biotin purification tag coding region upstream of the multiple cloning 
region (figure 4.4a): this encodes a peptide which becomes biotinylated in E. coli 
allowing the protein of interest to be purified. 
2.4.7.1 Ligation of DNA into vector 
The PinpointTM Xa vector system exploits the property of Taq DNA polymerase to 
add a single deoxyadenosine to the 3 end of the PCR product.  The linearised 
PinpointTM Xa vector has complimentary 3 overhanging deoxythymidine residues 
thus improving the efficiency of ligation of the PCR product into the plasmid.  
Promega supplied control DNA (368bp) which encodes the lacZ α-peptide.  When 
cloned into the vector a fusion protein is created between the biotinylation segment 
and the α-peptide.  For ligation, 7µl of fresh PCR product or 3µl of the control DNA 
or distilled water (negative control) were mixed with 1µl of vector, 1µl of 10x T4 
DNA ligase buffer and 1µl of T4 DNA ligase and incubated at 15°C overnight. 
2.4.7.2 Transformation of competent Escherichia coli 
High efficiency JM109 competent cells (Promega) were used.  Aliquots of competent 
cells (50µl) were gently mixed with 3µl of plasmid DNA from the ligation step and 
incubated on ice for 30 minutes.  Cells were then heat shocked at 42°C for 50 
seconds followed by incubation on ice for 2 minutes.  Following the addition of 
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500µl SOC medium (Invitrogen), the cells were gently mixed (225rpm) for 1 hour at 
37°C.  The cells were pelleted at 2500G for 3 minutes, the supernatant removed and 
the cells resuspended in 100µl SOC medium and spread onto prewarmed LB (Luria-
Bertani) agar (Life Technologies) selective plates containing 50µg/ml ampicillin.  
Plates were then incubated overnight at 37°C.  Eight colonies from the PCR insert 
plate were picked and incubated in 5ml LB with 50µg/ml ampicillin and grown 
overnight at 37°C with shaking.  The DNA was purified using the QIAprep Miniprep 
system (Qiagen, Crawley) as above.  
2.4.7.3 Restriction enzyme digest 
The purified plasmid DNA was digested in a 10µl volume containing 1µl 10x 
reaction buffer and 0.5µl enzyme (Promega) for 2 hours at 37°C.  The products of 
digestion were resolved on agarose gels and visualised using ultraviolet light as 
previously described. 
2.4.7.4 DNA sequencing 
The plasmid containing the insert in the correct orientation was identified using 
restriction enzyme digest.  A sample containing 2µg of the purified plasmid DNA 
was made up to 5µl with distilled water before 0.5µl 3M sodium acetate pH 5.2 
(check) and 12.5µl 100% ethanol were added.  Samples were left for 1 hour at -20°C.  
The precipitated DNA was spun down at 15000rpm at 4°C for 10 minutes and 
washed with 500µl 70% ethanol.  The pellet was air dried for 1 hour.  Using SP6 
primers, DNA encoding the insert was sequenced commercially by MWG Biotech.  
The cloned sequence was verified using DNA Strider 1.3f8 with the Fas receptor 
sequence in the NCBI nucleotide database (NM_000043). 
2.4.8 Protein Purification 
The biotinylated fusion product produced in E.Coli (JM109) was purified using the 
SoftLink Soft Release Avidin Resin (Promega, Madison, USA).  This resin allows 
elution of the protein under non-denaturing conditions.  E. coli produce a single  
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endogenous biotinylated protein, biotin carboxyl carrier protein (BCCP), (22.5kDa) 
that, in its native conformation, does not bind to avidin.  This renders the affinity 
purification highly specific for the recombinant fusion protein.  The resin is 
monomeric avidin and the biotinylated fusion protein is eluted from the resin in a 
non-denaturing 5mM biotin solution. 
2.4.8.1 Large scale culture and induction 
A freshly isolated bacterial colony (clone 4) was incubated in 5ml of LB (Luria-
Bertani), containing biotin (2µM final concentration) and ampicillin (50µg/ml), 
overnight at 37°C with shaking.  The 5ml culture was then transferred to 500ml LB 
(Lubia-Bertani), containing biotin (2µM final concentration) and ampicillin 
(50µg/ml) and incubated for 2 hours at 37°C with shaking.  Protein expression was 
induced by adding isopropyl β-D-thiogalactopyranoside (IPTG) (100µM final 
concentration) and incubating for a further 5 hours at 37°C with shaking. 
2.4.8.2 Bacterial cell lysis 
The cells were pelleted at 4000G for 10 minutes and the supernatant discarded.  The 
cells were weighed and resuspended in 10 volumes (ml/gram cell paste) of cell lysis 
buffer (50mM Tris-HCl (pH 7.5), 50mM NaCl, and 5% glycerol) containing 
phenylmethylsulfonyl fluoride (PMSF) (final concentration 1mM) at 4°C. 
2.4.8.3 Lysozyme/Detergent method 
Lysozyme (final concentration of 1mg/ml) was added and the solution continuously 
stirred for 20 minutes at 4°C.  Triton X (final concentration 0.1%) was added and 
stirring continued for five minutes at 4°C.  DNase I (200U) was added to reduce the 
viscosity of the solution and stirring continued for an additional 10 minutes.  The 




2.4.8.4 Preparation and regeneration of SoftLink Resin  
At room temperature, the column was equilibrated with 0.1M NaPO4 (pH 7.0).  The 
non-reversible binding sites on the fresh SoftLink Resin were preabsorbed by 
washing with 5mM biotin in 100mM sodium phosphate buffer (pH 7.2) at a flow rate 
of 6ml biotin/hour/ml of SoftLink Resin until two column volumes had passed 
through.  The flow was stopped for 15 minutes to allow biotin binding.  The column 
was then regenerated by washing the column with 8 column volumes of 10% acetic 
acid, then 8 column volumes of 100mM NaPO4 (pH 7.0).  The pH of the eluate was 
monitored until it reached pH 6.8. The flow was then stopped for 30 minutes to allow 
the avidin to refold and finally the column was re-equilibrated with cell lysis buffer. 
2.4.8.5 Resin column protein purification 
The supernatant (cell extract) was applied to the prepared resin column (6ml/hour) at 
4°C.  The column was then washed with five column volumes of cell lysis buffer and 
to elute the protein, a stabilizing buffer containing 5mM biotin was added.  Initially a 
0.5ml fraction was collected and the flow stopped for 15 min to increase the 
concentration of protein in the eluate before restarting collection of 0.5ml fractions.  
The fractions were tested and protein concentration quantified by monitoring the 
absorbance at A280.  Proteins from each fraction were then run on a 12% SDS gel, 
transferred to a nitrocellulose membrane and detected using HRP-Streptavidin 
(1:2500). 
2.5 Statistics 
All values are presented as mean + SEM.  The data were evaluated statistically as 





Figure Page Test Post-test 
3.1(c) 58 ANOVA Student-Neuman-Keuls 
3.2(b) 59 ANOVA Student-Neuman-Keuls 
3.3(b) 60 ANOVA Student-Neuman-Keuls 
4.1(a) 81 ANOVA Student-Neuman-Keuls 
4.1(b) 81 ANOVA Student-Neuman-Keuls 
4.2(a) 82 ANOVA Student-Neuman-Keuls 
4.2(b) 82 ANOVA Student-Neuman-Keuls 
4.3(a) 83 ANOVA Student-Neuman-Keuls 
4.3(b) 83 ANOVA Student-Neuman-Keuls 
4.3(c) 83 ANOVA Student-Neuman-Keuls 
4.4(b) 84 ANOVA Student-Neuman-Keuls 
4.5(a) 85 ANOVA Student-Neuman-Keuls 
5.1(b) 103 ANOVA Student-Neuman-Keuls 
5.2(a) 104 ANOVA Student-Neuman-Keuls 

















Figure. 2.1. Granulocytes and macrophages (a) Freshly isolated granulocytes (light 
microscopy under oil immersion, x100 objective,) (b) Human peripheral blood 
mononuclear cell-derived macrophages (day 5) cultured in IMDM with 10% 























Figure 2.2 Fresh and apoptotic neutrophils (a) Morphology (i) Fresh neutrophils (ii) 
Apoptotic neutrophils (light microscopy under oil immersion  x100 objective) (b) 
Apoptosis assessed by flow cytometry with apoptotic cells showing Annexin V 
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Table 2.2 Antibodies used in immunoblotting 
 
Protein Source Primary Antibody Secondary Antibody 
Rabbit anti-
human IκB-α 

















Table 2.3 Antibodies 
Immunogen Antibody Application Manufacturer 
Human Fas (Apo-1, 
CD95) 
Mouse anti-human Fas, clone CH11 Activating Upstate 
Human Fas (Apo-1, 
CD95) 
Mouse anti-human Fas, clone ZB4 Antagonistic Upstate 
Human FasL (CD95L) Mouse anti-human FasL, clone 
NOK-1 
Inhibitory BD Biosciences 
Human FasL (CD95L) Mouse anti-human FasL, clone 33 WB BD Transduction 
Soluble human FasL Mouse anti-human FasL/FITC, 
clone Alf-2.1a 
FACS Ancell 
Human Caspase-8 Mouse anti-human caspase-8, clone 
4-1-20 
WB BD Pharmingen 
IκB-α Rabbit anti- IκB-α WB Cell Signalling  
Technology 
Human/mouse FLIP Rabbit anti-human/mouse FLIP WB R&D Systems 
Human TNF-α Mouse anti-human TNF-α Inhibitory R&D Systems 
Human CD16 Mouse anti-human CD16 FACS Beckman Coulter 
Human CD14 Mouse anti-human CD14 FACS Beckman Coulter 
Human CD64 Mouse anti-human CD64 FACS Ancell 
Human HLA-DR Mouse anti-human HLA-DR FACS Sigma 
FACS: Fluorescent activated cell sorting 
WB: Western Blotting 
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Table 2.4 Pharmacological Inhibitors 
 




p38 MAPK SB 203580 Calbiochem 
p42/44 ERK PD 98059 Cell Signaling 
Phosphatidylinositol 3-
kinase (PI 3-kinase) 
LY 294002 Calbiochem 
Protein kinase C Ro-31-8220 Calbiochem 
Protein kinase Cδ Rottlerin Calbiochem 







Table 2.5 Recombinant proteins 
 
Recombinant protein Manufacturer 
FLAG-tagged soluble human FasL (SUPERFas 
Ligand)  
Alexis Corporation 
Human GM-CSF R&D Systems 






Alexis Biochemicals Corporation, San Diego, CA, USA 
Ancell Corporation, North Bayport, MN, USA 
Bachem, Bubendorf, Switzerland 
BD Biosciences, San Jose, CA, USA 
Beckman Coulter, Fullerton, CA, USA 
Biomol, Plymouth Meeting, PA, USA 
Calbiochem, Nottingham, UK 
Cell Signaling Technology, Beverly, MA, USA 
R&D Systems, Minneapolis, MN, USA 





Neutrophil Apoptosis and Fas/FasL 
 
3.1 Introduction  
During apoptosis, the neutrophil undergoes cell shrinkage, chromatin condensation, 
membrane blebbing and loses the multilobed shape of its nucleus.  The apoptotic 
bodies are then eaten by phagocytes such as macrophages (Savill et al., 1989).  If 
aged neutrophils are not effectively phagocytosed, they release their potentially 
injurious contents into the surrounding inflamed tissue which may potentiate tissue 
injury (Mecklenburgh et al., 1999).  Furthermore, when macrophages ingest 
apoptotic neutrophils, they switch to an anti-inflammatory phenotype (Fadok et al., 
1998).  The discovery of this mode of cell clearance explained how cells are 
effectively removed without inciting an inflammatory response (diagram 3.1.). 
At a molecular level, the apoptotic neutrophil displays different surface receptors.  
Immunoglobulin superfamily members including CD31 (PECAM-1), CD50 (ICAM-
3), CD63 and CD87 (urokinase plasminogen activator receptor) are downregulated.  
There is also reduced expression of receptors involved in the inflammatory process 
including CD32 (FcγRII), CD35 (CR1), and CD88 (C5a receptor).  CD16 (FcγRIII), 
CD15 (Lex) and CD120b (TNF-α receptor) are shed from the cell surface while the 
phosphatidylserine receptor becomes externally exposed and apoptotic neutrophils 
are therefore able to bind fluorescently-labelled- Annexin V (Dransfield et al., 1994; 
Homburg et al., 1995; Hart et al., 2000).  At a functional level, apoptotic neutrophils 
in vitro are less responsive to external stimuli including fMLP.  Other cellular 
functions including chemotaxis, adhesion, phagocytosis, enzyme secretion and 
generation of a respiratory burst are downregulated (Whyte et al., 1993; Dransfield et 
al., 1995). The DNA of apoptotic neutrophils also undergoes cleavage to form a 
characteristic nucleosomal ladder (Wyllie, 1980). 
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Neutrophils are short-lived and the majority undergo spontaneous apoptosis in less 
than 24 hours (Colotta et al., 1992; Squier et al., 1995).  They have been shown to 
express Fas and anti-Fas antibody accelerated their apoptosis (Iwai et al., 1994).  
Neutrophils also express FasL and release sFasL which can induce death in activated 
Jurkat cells (Liles et al., 1996).  Furthermore blocking the Fas receptor, partially 
suppressed spontaneous neutrophil apoptosis suggesting that the Fas/FasL may 
mediate neutrophil apoptosis by both an autocrine and paracrine pathway (Liles et 
al., 1996).  Therefore, this Fas-mediated fratricide in spontaneous neutrophil 




3.2  Results 
3.2.1 Fas is functionally expressed on the surface of human neutrophils 
The death receptor Fas is expressed in various tissues.  We demonstrated that it was 
expressed on neutrophils using indirect immunofluorescent labelling with the mouse 
anti-human Fas IgG monoclonal Ab (mAb), ZB4 (figure 3.1a).  This has previously 
been shown with the FITC-conjugated anti-human Fas mAb, UB2 (Liles et al., 1996; 
Renshaw et al., 2000).  The activating anti-Fas antibody, CH-11, induces apoptosis 
in Fas-expressing cells.  It also induced apoptosis in neutrophils at an optimum 
concentration of 500ng/ml (figure 3.1b).  Neutrophils were short-lived, in vitro, with 
70% of neutrophils undergoing apoptosis by 20 hours (figure 3.1c).  The levels of 
spontaneous and Fas-induced neutrophil apoptosis were highest at 3 hours in a 
serum-free system, (Pbs, 34.9 + 3.7%; CH-11, 64.5 + 7.4%, n=3, p<0.01) however 
by 20 hours, cells cultured in serum-free media were necrotic as assessed by their 
inability to exclude trypan blue.  In the presence of serum, the spontaneous rates of 
apoptosis were not affected by the type of serum however the induction of apoptosis 
by CH-11 was significantly greater at both 3 hours (As.CH-11, 26.1 + 4.4%; 
Fbs.CH-11, 57.1 + 6.8%, n=3, p<0.001) and 20 hours (As.CH-11, 69.1 + 4.8%; 
Fbs.CH-11, 89.2 + 2.6%, n=3, p<0.05) when the cells were cultured in the presence 
of foetal bovine serum (Fbs). 
3.2.2 Anti-Fas antibodies 
There are several anti-Fas antibodies (Komada et al., 1999).  The prototype agonistic 
anti-Fas antibody (CH-11) is an IgM antibody while the antagonistic antibody (ZB4) 
is an IgG antibody.  Both CH-11 and ZB4 bound to the Fas receptor (figure 3.2a) but 
the binding of CH-11 was not saturated at concentrations (500ng/ml) which 
maximally induced neutrophil apoptosis (figure 3.1b).  CH-11 and ZB4 have been 
shown to bind to the same epitope on the Fas protein however ZB4 has a much 
greater affinity (Komada et al., 1999).  It has been suggested that serial triggering of 
the Fas receptor, due to the IgM monoclonal antibody having a weak affinity, may 
explain the agonistic properties of CH-11 while the antagonistic IgG antibody has a 
strong affinity (Komada et al., 1999).  ZB4 (500ng/ml) had no effect on spontaneous 
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neutrophil apoptosis (control, 4.1 + 0.8%; ZB4, 4.8 + 1.0%) and when neutrophils 
were pre-incubated with ZB4 for 1 hour, it completely inhibited CH-11-induced 
apoptosis (CH-11, 30.5 + 3.1%; ZB4.CH-11, 4.7 + 1.1%, n=3, p<0.001) (figure 
3.3b).  This suggests that Fas/FasL is not an important mechanism of spontaneous 
neutrophil apoptosis and that CH-11 mediated its effect through the Fas death 
receptor alone.  Caspases are known to be important mediators downstream of death 
receptors.  The poly-caspase inhibitor, zVAD (control, 4.1 + 0.8%; zVAD 3.8 + 
0.4%) had no effect on spontaneous neutrophil apoptosis but completely inhibited 
CH-11-induced apoptosis (CH-11, 30.5 + 3.1%; zVAD, 3.7 + 0.5%, n=3, p<0.001).  
This suggests that caspases are important in the Fas/FasL death receptor pathway in 
neutrophils.  Contrary to our observations, there is also data suggesting that 
spontaneous neutrophil apoptosis is caspase dependent (Pongracz et al., 1999). 
3.2.3 FasL and Neutrophil Apoptosis 
Human FasL is physiologically active in its membrane-bound form.  When it is 
cleaved by metalloproteases to a soluble form, sFasL, its pro-apoptotic activity is 
downregulated (Schneider et al., 1998; Tanaka et al., 1998).  Furthermore only 
multimerized or membrane-bound FasL induced apoptosis of murine granulocytes 
(Villunger et al., 2000).  SUPERFasLigand (Alexis) is genetically engineered human 
soluble recombinant FasL with a FLAG-tag and is biologically active (Thilenius et 
al., 1997).  Preliminary results showed that SUPERFasLigand (rhFasL) induced 
apoptosis in both Jurkat cells (human leukaemic T lymphocyte cell line) and human 
neutrophils however Jurkat cells were more sensitive (figure 3.3a).  The agonistic 
antibody CH-11 (38.1% + 4.2%) induced significantly more neutrophil apoptosis 
than rhFasL (8.6% + 2.3 %, n=3, p<0.001).  The anti-human FasL monoclonal 
antibody, NOK-1, has been shown to neutralize the cytotoxic activity of FasL 
(Kayagaki et al., 1995; Orlinick et al., 1997; Oyaizu et al., 1997; Villunger et al., 
1997; Walker et al., 1997).  Pre-incubation with the anti-FasL antibody, NOK-1 and 
the anti-Fas antibody, ZB4 inhibited the cytotoxic effect of rhFasL (figure 3.3b).  
However, the effect of the agonistic anti-Fas antibody CH-11 (38.1 + 4.2%) was also 
significantly inhibited by NOK-1 (27.6 + 7.2%, n=3, p<0.05) and ZB4 (5.7 + 1.4%, 
n=3, p<0.001) (figure 3.3b).  Furthermore NOK-1 had no effect on spontaneous 
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neutrophil apoptosis.  This suggests that NOK-1 partially inhibits CH-11  induced 
neutrophil apoptosis although the mechanism is not known.  Both NOK-1 and ZB4 
had no effect on spontaneous neutrophil apoptosis which suggests that the Fas/FasL 
pathway in neutrophils is unlikely to mediate suicide or fratricide. 
3.2.4 FasL expression on the neutrophil 
The seminal paper in this field suggested that neutrophils express Fas and FasL 
(Liles et al., 1996).  Initially, to assess cell surface FasL by flow cytometry and 
whole cell FasL by Western blotting, a gift of FasL stably transfected A549 (lung 
adenocarcinoma cell line) cells were used as a positive control while Jurkat cells 
(human T-cell leukaemia cell line) were used as negative control (Smith et al., 1998).  
Using an anti-human FasL monoclonal antibody, clone 33 (Transduction), FasL was 
shown to be present by Western blotting in Jurkat cells, control A549 cells and two 
stably transfected A549 cell lines (PC3 and PC4) (figure 3.4a).  As the negative 
control Jurkat cell line, the control A549 cells and the transfectants all expressed 
FasL, we compared messenger ribonucleic acid (mRNA) levels of FasL in these cells 
to those of the myeloid leukaemia cell line, K562 and its FasL stable transfectant, 
KFL9.  It has been shown that the K562 cell line does not express surface FasL while 
the stable transfectant KFL9 does express FasL (Renshaw et al., 2000).  Using RT-
PCR, we showed that neither the A549, PC3, PC4 nor K562 cell line expressed 
mRNA for FasL whilst the KFL9 cell line did express mRNA for FasL (figure 3.4b).  
Thus PC3 and PC4 were not stably transfected with FasL and the anti-FasL 
monoclonal antibody, clone 33 appears to bind non-specifically to a 37kDa protein. 
Monocytes have mRNA for FasL but only express it on the surface when activated 
(Lu et al., 2002).  Using the same primers as above, we showed using RT-PCR, that 
fresh neutrophils and K562 cells do not express mRNA for FasL whilst mononuclear 
cells and KFL9 cells do express mRNA for FasL (figure 3.5a).  Furthermore, using a 
FITC-conjugated anti-human FasL monoclonal antibody, Alf-2.1a (Ancell), KFL9 
cells expressed FasL on their surface but neither fresh neutrophils, mononuclear cells 




Neutrophil death by apoptosis is important in resolution of inflammation.  If a 
neutrophil is allowed to die by primary or secondary necrosis, it will release its pro-
inflammatory granules and induce or exacerbate tissue injury. 
Human neutrophils undergo spontaneous apoptosis in vitro.  The mechanisms 
controlling constitutive neutrophil lifespan are not clear.  Akgul et al, (2000) 
proposed that control of the transcription and translation of short-lived, anti-apoptotic 
proteins, A1 and Mcl -1 may be important in determining neutrophil lifespan.  
Neutrophils are destined to die as they constitutively express the pro-apoptotic 
proteins Bax, Bid, Bak and Bad which have a long half-life and therefore the relative 
levels of the opposing anti-apoptotic proteins, A1 and Mcl-1 may be the key in 
determining the neutrophils fate.  It has been suggested that the Fas/FasL pathway 
may be important in constitutive neutrophil apoptosis since the antagonistic anti-Fas 
monoclonal antibody, ZB4 delayed spontaneous neutrophil apoptosis in vitro (Liles 
et al., 1996).  However, we have shown that when neutrophils were cultured in 
phosphate buffered saline, ZB4 had no effect on constitutive neutrophil apoptosis.  In 
addition, the neutralizing anti-FasL antibody (NOK-1) had no effect on constitutive 
neutrophil apoptosis.  This confirmed that the Fas/FasL pathway is not important in 
spontaneous neutrophil apoptosis (Brown and Savill, 1999; Renshaw et al., 2000).  
Furthermore, both fresh and inflammatory neutrophils from Fas/FasL-deficient mice 
undergo constitutive apoptosis at the same rates as neutrophils from wild-type mice 
(Fecho et al., 1998; Villunger et al., 2000).  Although spontaneous neutrophil 
apoptosis was independent of the Fas death receptor, other groups have shown that 
caspase 8 is important (Khwaja and Tatton, 1999; Daigle et al., 2002).  Recently it 
was shown that as neutrophils age, reactive oxygen species accumulate and via acid 
sphingomyelinase trigger lipid raft clustering of the death-inducing signalling 
complex components, including caspase 8, thus initiating apoptosis (Scheel-Toellner 
et al., 2004). 
Death receptors belong to the tumour necrosis receptor family.  Currently seven 
receptors, namely TNF-R1, Fas, TRAMP/DR3, TNF-related apoptosis-inducing 
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ligand- receptors 1,-2, -3 (TRAIL-R1/ TRAIL-R2/TRAIL-R3) and decoy receptor 6 
(DR6) have been identified that signal through an intracellular death domain.  
TNF-α, induces neutrophil apoptosis in vitro at early time points (up to 8 hours) and 
survival at later time points (Murray et al., 1997).  Neutrophils have also been shown 
to be susceptible to anti-Fas - mediated cell death (Iwai et al., 1994).  We have 
shown that the activating anti-Fas antibody (CH-11) optimally activated neutrophil 
apoptosis in vitro at 500ng/ml and had a greater effect at earlier time points.  The 
anti-Fas antibody loses its potency over time hence the variability between 
experiments.  Within experiments, variability in anti-Fas antibody potency was 
minimized by repeating individual experiments in as short a period as possible. 
Autologous serum attenuated the effect of CH-11 at 3 hours while completely 
inhibiting its effect at 20 hours.  When peripheral blood neutrophils from post-
surgery patients were treated with CH-11 in vitro, autologous plasma significantly 
attenuated the effect of CH-11 (Iwase et al., 2006).  Some cytokines have been 
shown to delay neutrophil apoptosis (Ward et al., 1999) and the attenuation of the 
effect of CH-11 by autologous serum may be due to the presence of cytokines in the 
serum.  However, in the post-surgical patients, neutralization of either granulocyte-
macrophage colony stimulating factor (GM-CSF), interleukin-6 (IL-6) or interleukin-
8 (IL-8) had no effect on the attenuation of CH-11-induced apoptosis mediated by 
plasma (Iwase et al., 2006).  The mechanism by which serum attenuates Fas-
mediated neutrophil apoptosis requires further elucidation.  Interestingly, sera from 
patients with infection, has been shown to induce neutrophil apoptosis in vitro.  This 
was partially attenuated by anti-FasL antibody.  Infection was associated with 
increased monocyte expression of FasL and increased serum levels of FasL 
(Nwakoby et al., 2001).  The Fas-triggered neutrophil apoptosis was caspase-
dependent unlike TNF-α - induced neutrophil apoptosis which also has a caspase-
independent death pathway (Maianski et al., 2003).  Recently two more death 
receptors, TRAIL-R2 and TRAIL-R3 were found to be expressed on neutrophils and 




The Fas/FasL pathway is important in peripheral deletion of activated T cells.  Fresh 
cytotoxic T cells do not express FasL but upon T receptor ligation, the Fas ligand 
gene on chromosome 1 is transcribed and translated (Suda et al., 1995; Tanaka et al., 
1995; Vignaux et al., 1995).  Jurkat cells (human leukaemic T lymphocyte cell line) 
have been shown to constitutively express FasL using the non-specific polyclonal 
anti-FasL (N20) antibody (Santa Cruz) (Martinez-Lorenzo et al., 1996) however 
using Alf1.2 and NOK-1 they do not express FasL (Smith et al., 1998).  We have 
also shown that Jurkat cells do not express mRNA for FasL.  However upon 
activation, cytotoxic T cells, which initially store newly synthesized FasL in their 
lytic granules, direct their lytic granules to the area of T cell surface in tight contact 
with the target cell by a process of polarized degranulation (Bossi and Griffiths, 
1999).  Furthermore, microvesicles expressing bioactive FasL and APO2 
ligand/TNF-related apoptosis-inducing ligand (TRAIL) are released from Jurkat cells 
upon mitogenic stimulation (Martinez-Lorenzo et al., 1999).  Macrophages, upon 
phagocytosis of opsonized zymosan, also release bioactive FasL in microvesicles 
(Brown and Savill, 1999). 
Soluble FasL (sFasL) is released from the membrane and it can block the apoptosis 
induced by the intact membranous form (Kayagaki et al., 1995; Suda et al., 1995; 
Tanaka et al., 1995).  While multimerized FasL induced Jurkat cell apoptosis, sFasL 
had minimal effects even at very high concentrations (Schneider et al., 1998).  
Furthermore, only multimerized sFasL has been shown to induce apoptosis of murine 
bone-marrow derived granulocytes (Villunger et al., 2000).  In these studies, 
SUPERFasLigand (rhFasL) (Alexis Biochemicals) was used and while it induced 
human neutrophil apoptosis, Jurkat cells were more sensitive.  The neutrophil 
apoptosis induced by rhFasL could be neutralized by the anti-FasL antibody, NOK-1 
or apoptosis inhibited by pre-incubation with the anti-Fas antibody ZB4.  We also 
found that, in human neutrophils, the agonistic anti-Fas antibody (CH-11) was a 
more potent inducer of apoptosis than rhFasL. 
We have shown that human neutrophils express Fas. This is widely accepted (Liles et 
al., 1996; Renshaw et al., 2000).  However the expression of FasL by human 
neutrophils and its role in mediating autocrine and paracrine cell death is 
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controversial.  Liles et al (1996), in their seminal paper, showed that neutrophils 
express FasL on their surface using a Fas-immunoglobulin (Fas-Ig) fusion protein 
and indirect immunofluorescence.  They also showed FasL protein expression by 
Western blotting using the anti-FasL monoclonal antibody, clone 33 (Transduction).  
Genetically-engineered antibodies are becoming more important as tools for 
scientists.  However badly engineered tools can give misleading results; using a 
polyclonal rabbit immunoglobulin raised against a C-terminal peptide from FasL 
(Santa-Cruz), neutrophils express FasL (Mincheff et al., 1998) however this antibody 
has been shown to bind non-specifically, when used in flow cytometry to detect 
surface expression of FasL (Smith et al., 1998).  Furthermore there have been 
conflicting results regarding FasL expression in thyrocytes; Stokes et al (1998) 
showed that when the anti-FasL monoclonal antibody, clone 33 (Transduction), is 
used in Western blotting, it binds non-specifically to FasL.  We have also shown that 
this mAb, clone 33, bound to a 37kDa protein in Jurkat cells and A549 cells, both of 
which are known to lack FasL expression (Smith et al., 1998).  A second anti-FasL 
monoclonal antibody, G247-4 (Transduction) has been used in Western blotting to 
show the upregulation of FasL expression in activated cytotoxic T cells (Bossi and 
Griffiths, 1999) however when we used this antibody, we were unable to block non-
specific protein binding.  The anti-FasL monoclonal antibodies, NOK-1 and Alf-2.1a 
bind specifically to FasL and have been used in flow cytometry to detect surface 
expression of FasL (Smith et al., 1998; Renshaw et al., 2000).  We have shown, 
using Alf-2.1a, that neutrophils do not express surface FasL. 
In view of these conflicting results, we also looked at the mRNA expression of FasL 
using the reverse transcription polymerase chain reaction (RT-PCR).  We showed 
that A549 cell lines, that were thought to be stably-transfected with FasL, did not 
in fact express mRNA for FasL.  Furthermore, neutrophils did not express mRNA for 
FasL but KFL9 cells and mononuclear cells did.  Previously, Brown & Savill (1999) 
have suggested that neutrophils do not express FasL, by Western blotting and RT-
PCR.  However they used the monoclonal antibody (clone 33) whose specificity for 
FasL has been challenged (Stokes et al, 1998) but they showed that clone 33 cross-
reacts with β-actin (Brown and Savill, 1999).  Subsequently Renshaw et al, (2000), 
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found that both fresh and ageing neutrophils, as well as activated neutrophils, do not 
express FasL using RT-PCR.  They also failed to show surface FasL expression on 
neutrophils using the monoclonal antibody, Alf-2.1.  Subsequently three studies, to 
date, have been published showing FasL expression on neutrophils (Jaber et al., 
2001; Kim et al., 2001; Hu et al., 2005).  Contaminating mononuclear cells which 
have mRNA for FasL may account for the neutrophil expression of FasL seen by 
Jaber et al (2001) and Hu et al (2005).  Although, Kim et al, (2001) used the non-
specific monoclonal antibody (clone 33), they also showed mRNA expression of 
FasL in highly purified neutrophil preparations.  The reason for this disparity is not 
clear. 
We have confirmed earlier findings that neutrophils do not have mRNA for FasL and 
do not express FasL on their surface.  Monoclonal antibodies with a high specificity 
for FasL were used in these experiments.  As a consequence, the Fas/FasL pathway 
does not have a role in mediating constitutive neutrophil apoptosis.  However 
triggering of the Fas death receptor pathway by anti-Fas monoclonal antibodies or 
multimerized recombinant FasL does accelerate neutrophil apoptosis but their effect 
is attenuated by factors in serum.  Furthermore, Fas-mediated induction of neutrophil 



















Figure 3.1.  Fas and the neutrophil  
(a) Expression of Fas on neutrophil surface assessed by flow cytometry.  Isotype control 
antibody is shown as an outline curve.  Specific binding of Fas is shown as a shaded curve.  
Freshly isolated human neutrophils were labelled with anti-Fas antibody ZB4 (1:40) and 
detected with FITC-conjugated goat anti-mouse immunoglobulin (1:40). (b) PMN (5 x 
106/ml) were cultured in phosphate buffered saline (Pbs) with 10% foetal bovine serum (Fbs) 
with a control IgM antibody and varying concentrations of the agonistic anti-Fas antibody, 
CH-11.  Apoptosis was assesses at 3 hours by Annexin V binding.  (c) PMNs (5 x 106/ml) 
were cultured in Pbs with 10% autologous serum (As), 10% Fbs and CH-11 (500ng/ml).  















































































Figure 3.2.  Agonistic and antagonistic anti-Fas antibodies 
(a) Binding of CH-11 and ZB4 to Fas on neutrophils as assessed by flow cytometry. Freshly 
isolated human neutrophils were labelled with anti-Fas antibody (agonistic IgM antibody, 
CH-11 and antagonistic IgG antibody, ZB4) and detected with FITC-conjugated goat anti-
mouse immunoglobulin (1:40) (n=1).  (b) Neutrophils (5 x 106/ml) in Pbs, 10% Fbs were 
pre-incubated for 1 hour in a shaking water bath with either Pbs and 10% Fbs, ZB4 
(500ng/ml) or zVAD (100µM).  They were then incubated for a further 3 hours in flexi-well 
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Figure 3.3. FasL and the neutrophil 
(ai) Neutrophils (5 x 106/ml) in Pbs and 10% Fbs were incubated with varying 
concentrations of rhFasL for 3h and apoptosis assessed by Annexin V (n=1). (aii)  Jurkat 
cells (5 x 106/ml) in RPMI and 10% Fbs were incubated with varying concentrations of 
rhFasL and apoptosis assessed at 3h by morphology (n=1).  (b) Neutrophils (5 x 106/ml) in 
Pbs and 10% Fbs were pre-incubated for 1 hour in a shaking water bath with either Pbs and 
10% Fbs,  NOK-1(10µg/ml) or ZB4 (500ng/ml).  They were then incubated for a further 3 
hours in flexi-well plates with or without rhFasL (500ng/ml) or CH-11 (500ng/ml).  




































































Figure 3.4 FasL protein and mRNA expression. 
(a) The Jurkat cell line was grown to 1 x 106/ml and the cells harvested.  The A549 cell line 
and FasL transfected A549 cell lines (PC3 and PC4) were grown to 90% confluency and 
harvested from plates using trypsin/EDTA.  The Jurkat, A549, PC3 and PC4 cells were 
lysed, quantity of protein estimated and Western blotting carried out using 5µg/ml Clone 33 
(Transduction) as described in the methods. (b) Total cellular RNA was extracted using the 
Trizol method from 5 x 106 cells: A549 cell lines stably transfected with FasL (PC1, PC3 
and PC4), the parent cell line K562 and the K562 cell line stably transfected with FasL 
(KFL9).  FasL and GAPDH mRNA was demonstrated by RT-PCR using specific primers.  
38 
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Jurkat A549  PC3  PC4
PC1 PC3 PC4 K562 KFL9 ve PC1 PC3 PC4 K562 KFL9 ve 
                  FasL                                             GAPDH 
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a) mRNA levels by PCR 
 
 





Figure 3.5. FasL expression by the neutrophil. 
(a) Total cellular RNA was extracted, using the Trizol method, from 10 x 106 cells (fresh 
neutrophils (PMN), mononuclear cells (mono), the parent cell line K562 and the K562 cell 
line stably transfected with FasL, (KFL9).  FasL and GAPDH mRNA was demonstrated by 
RT-PCR using specific primers.  (b) Surface expression of FasL on neutrophils (PMN), 
mononuclear cells, K562 and KFL9s by flow cytometry.  Isotype control antibody is shown 
as a blue curve.  Specific binding of FasL (Alf-2.1a) is shown as a purple curve.  Freshly 
isolated human cells were labelled with FITC-conjugated anti-human FasL antibody (Alf-
2.1a) (1 in 50) or FITC-conjugated isotype control (1 in 50). 
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Diagram 3.1 The fate of an inflammatory neutrophi 
The multilobed neutrophil accumulates at sites of inflammation.  It can either die by 
apoptosis or necrosis.  The apoptotic form of cell death results in cell shrinkage and DNA 
condensation but the plasma membrane remains intact.  The apoptotic neutrophil is usually 
phagocytosed by a tissue macrophage but if this process is delayed or perverted it will 
undergo secondary necrosis.  Necrosis is deleterious as it results in cell membrane damage 












Signalling in the neutrophil: to live or die 
 
4.1  Introduction 
In acute respiratory distress syndrome (ARDS), the balance of pro-inflammatory and 
anti-inflammatory mediators will help determine the fate of the neutrophil.  In the 
inflammatory milieu, inflammatory mediators and cytokines are present which are 
produced locally by inflammatory cells, lung epithelial cells and fibroblasts (Ware 
and Matthay, 2000; Park et al., 2001).  In the bronchoalveolar lavage fluid (BALF) 
of patients with ARDS both pro- and anti-inflammatory mediators have been 
detected.  Pro-inflammatory cytokines include tumour necrosis factor-α (TNF-α), 
interleukin-1β (IL-1β) and IL-6 (Siler et al., 1989; Suter et al., 1992; Schutte et al., 
1996; Park et al., 2001) while anti-inflammatory mediators include interleukin-10 
(IL-10), soluble TNF receptor I (sTNF-RI), soluble TNF receptor II (sTNF-RII), 
interleukin-1 receptor antagonist (IL-1ra) and soluble interleukin-1 receptor II (sIL-
1RII) (Suter et al., 1992; Donnelly et al., 1996; Park et al., 2001). 
The balance appears to favour anti-inflammatory cytokines during the early acute 
phase of ARDS which may be important in dampening the initial intense 
inflammation (Park et al., 2001).  During this early phase, BALF from ARDS 
patients has also been shown to delay neutrophil apoptosis in vitro; this inhibitory 
effect was largely attenuated by neutralizing granulocyte - colony stimulating factor 
(G-CSF) and granulocyte-macrophage - colony stimulating factor (GM-CSF) 
(Matute-Bello et al., 1997).  However our group found that BALF from patients with 
established ARDS was markedly pro-apoptotic for neutrophils (Donnelly & Haslett, 
unpublished observation). 
Inflammatory agents, including the bacterial endotoxin, lipopolysaccharide (LPS) 
have also been found in BALF (Martin et al., 1997).  Endotoxin plays a major role in 
ARDS secondary to sepsis (Ware and Matthay, 2000).  In experimental models, 
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intratracheal instillation of LPS produces a well-characterized response resembling 
acute lung injury in humans (Brigham and Meyrick, 1986; Xing et al., 1994). 
The fate of the neutrophil at an inflamed site will thus depend on the balance of pro- 
and anti-inflammatory mediators.  Studies have investigated the effect of cytokines 
and bacterial products on neutrophil lifespan in vitro; most cytokines and bacterial 
products appear to prolong neutrophil survival but the studies sometimes differ in 
their results with respect to individual inflammatory mediators (Ward et al., 1999). 
In 1892, the bacterial product endotoxin was first discovered by Richard Pfeiffer, a 
co-worker of Robert Koch.  Lipopolysaccharide (LPS) is released from Gram-
negative bacteria and in large quantities, it can trigger a detrimental immune 
response leading to septic shock (Nogare and Yarbrough, 1990).  However humans 
are continuously exposed to low levels of LPS which as an immunostimulatory 
molecule may be beneficial. 
LPS binds to a TLR-4/MD-2 complex which transduces the signal intracellularly 
however this signal is amplified by the cellular receptor, CD14 (Miyake, 2004).  
Furthermore a serum component, LPS-binding protein, is an opsonin, enhancing the 
binding of LPS to CD14  (Wright et al., 1990; Schumann, 1992).  Although LPS has 
been shown to delay neutrophil apoptosis (Lee et al., 1993), this effect has not 
always been seen (Dibbert et al., 1999).  It has been suggested that contaminating 
monocytes, due to differences in neutrophil preparation from human blood, may 
mediate the anti-apoptotic effect of LPS (Sabroe et al., 2002). 
Bacteria also produce proteins with an amino-terminal N-formylated methionine; the 
f-Met-Leu-Phe (fMLP) peptide is an important chemotactic factor for neutrophils 
and its receptor is a member of the serpentine receptor family.  These are seven 
trans-membrane spanning, G-protein coupled receptors (Boulay et al., 1990).  In 
vitro, fMLP has variably been reported to have no effect or to prolong the neutrophil 
lifespan (Colotta et al., 1992; Kettritz et al., 1997; Ottonello et al., 2002). 
However, it is widely accepted that GM-CSF delays neutrophil apoptosis (Brach et 
al., 1992; Colotta et al., 1992; Lee et al., 1993).  At sites of inflammation, CD4+ 
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lymphocytes are usually the major source of GM-CSF which as well as activating 
macrophages locally, also has a distant action on bone marrow where it promotes the 
proliferation and differentiation of myeloid precursors (DeLamarter, 1988). 
4.1.1 Signal Transduction Pathways 
In the past 50 years, the field of signal transduction has been born and our knowledge 
has exploded.  In the 1950s, Earl Sutherland and his colleagues discovered that the 
pathway downstream of adrenalin and glucagon receptors (both serpentine 
receptors) involved activation of the enzyme adenylate cyclase to generate adenosine 
cyclic 3΄5΄ monophosphate (cAMP), the second messenger.  This in turn activated 
protein kinase A.  However, central to cell signalling was the discovery by Edwin 
Krebs and Ed Fischer, again in the 1950s, that the process of phosphorylation by 
kinases and dephosphorylation by phosphatases was pivotal to the control of cell 
behaviour (Hunter, 2000). 
Another second messenger pathway downstream of serpentine receptors involves 
hydrolysis of the membrane phospholipid, phosphatidylinositol 4,5 biphosphate by 
phospholipase C (until the 1970s, lipids were considered inert, structural components 
of cell membranes).  This generates water soluble inositol 1,4,5-triphosphate which 
triggers a rise in intracellular Ca2+ which in turn activates many intracellular 
pathways.  Phospholipase C also produces a second lipid soluble product, 1,2-
diacylglycerol which activates one or more of the protein kinases C. 
4.1.2 The protein kinase C pathway 
The protein kinase C pathway appears to be involved in regulating spontaneous 
neutrophil apoptosis (Pongracz et al., 1999).  There are at least 11 isoenzymes which 
are subclassified into three groups, classical, novel and atypical depending on their 
mode of activation; the classical isoenzymes are -α, -β and -γ  and their activation is 
dependent on diacylglycerol (DAG) and calcium, the novel isoenzymes are -δ, -ε, -η 
and -θ and they are activated by DAG alone while the activation of the atypical 
isoenzymes -ζ and -ι  / λ are independent of DAG (Kent et al., 1996). 
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4.1.3 The mitogen-activated kinase pathway 
The mitogen-activated protein (MAP) kinase (MAPK) pathway is known to be an 
important mechanism by which cells control transcription (Seger and Krebs, 1995).  
It was originally discovered as an insulin-activated protein-serine kinase.  Each 
pathway consists of a cascade of three protein kinases; a MAP kinase kinase kinase 
(MAP3K), which phosphorylates serine residues in the MAP kinase kinase 
(MAP2K) thereby activating it, to in turn phosphorylate both a serine and a tyrosine 
residue in the MAP kinase (Waskiewicz and Cooper, 1995).  Once the terminal MAP 
kinase is activated, it can migrate into the nucleus where it phosphorylates and 
activates transcription factors.  There are three known mammalian MAP kinase 
cascades: the stress activated protein kinase 1 (SAPK1)/C-Jun N-terminal kinase 
(JNK) cascade, the SAPK2/p38 cascade and the p42/p44 ERK cascade (Wallach et 
al., 1999).  The three MAP kinase cascades have been shown to be expressed in 
human neutrophils (Nick et al., 1996).  There are 4 isoforms of p38 MAPK (-α, -β, -δ 
and -γ) however human neutrophils, only express p38 MAPKα as the dominant 
isoform with lower levels of p38 MAPKδ (Nick et al., 1999).  LPS has been shown 
to stimulate the α isoform of p38 MAPK resulting in NF-κB activation which in turn 
stimulates adhesion and TNF-α synthesis (Nick et al., 1999). 
4.1.4 The phosphatidylinositol 3-kinase pathway 
In neutrophils, the phosphatidylinositol 3 (PI 3)-kinase pathway is important in the 
GM-CSF-mediated prolongation of their lifespan (Vlahos et al., 1995; Klein et al., 
2000; Cowburn et al., 2002).  PI-3 kinase activates protein kinase B/Akt which is an 
anti-apoptotic signalling pathway (Zundel and Giaccia, 1998).  Phosphorylated Akt 
functions as a serine-threonine kinase and can phosphorylate Bad (Bcl-2/Bcl-XL-
antagonist causing cell death), a member of the Bcl-2 (B-cell leukaemia/lymphoma 
2) family.  Normally Bad promotes apoptosis by forming an inhibiting heterodimer 
with anti-apoptotic members of the Bcl-2 family.  When Bad is phosphorylated, its 
inhibitory effect is lost as it dissociates from the heterodimer to leave the active anti-
apoptotic Bcl-2 family proteins (Yang et al., 1995).  Prolongation of neutrophil 
apoptosis by GM-CSF was associated with increased Bad phosphorylation and 
decreased expression of Bad mRNA and this was inhibited by LY294002, a PI 3-
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kinase inhibitor (Cowburn et al., 2002).  Furthermore, activation of the PI 3-kinase 
pathway, in a cell-dependent manner can also lead to p42/p44 ERK activation 
(Hawes et al., 1996; Kilgour et al., 1996). 
4.1.5 The NF-κB pathway 
The NF-κB pathway is evolutionarily conserved and is believed to be the central 
signalling pathway of activation in the innate immune system.  The transcription 
factor, NF-κB, consists of homo- or heterodimers of the Rel family proteins 
(p50/NF-κB1, p52/ NF-κB2, p65/Rel A and c-Rel) which are sequestered in the 
cytoplasm due to their physical association with an inhibitory protein subunit termed 
(IκB) (Henkel et al., 1993).  Phosphorylation of IκB leads to its proteolytic 
breakdown in the proteasome and allows NF-κB to translocate to the nucleus (Finco 
et al., 1994; Traenckner et al., 1994) where it regulates transcription of many genes 
including those for pro-inflammatory cytokines.  In the neutrophil, IκB-α has been 
found in the cytoplasm associated with p50/c-Rel, p50/Rel A and p65/c-Rel 
heterodimers however in the nucleus the complexes contained p65/Rel A and p50 
(McDonald et al., 1997). 
The inflammatory mediators, LPS, fMLP and TNF-α have been shown to activate 
NF-κB (McDonald et al., 1997).  Furthermore we have previously shown that by 
blocking the translocation of an inducible form of NF-κB, neutrophil apoptosis 
induced by TNF-α, is accelerated (Ward et al., 1999).  However it is not known if 
Fas ligation results in NF-κB activation in human neutrophils. 
Prostaglandins are traditionally thought to be pro-inflammatory mediators however 
cyclopentenone prostaglandins (∆12 PGJ2 and 15-deoxy-∆12, ∆14- PGJ2), which are 
natural metabolites of PGD2 (diagram 4.1), have anti-inflammatory activity including 
inhibition of TNF-α induced IκBα degradation (Rossi et al., 2000).  Furthermore the 
resolution phase of pleurisy induced by carageenin in rats is associated with the 
production of prostaglandin D2 (PGD2) and 15dPGJ2 (Gilroy et al., 2003). 
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4.1.6 The Fas/FasL Receptor pathway 
The Fas receptor (CD95, APO-1) is a member of the TNF receptor family.  These 
receptors are type I receptors and their cytoplasmic tails have a sequence motif 
termed the death domain (DD) (Feinstein et al., 1995; Hofmann and Tschopp, 
1995).  This death domain interacts with adapter proteins which also bear a death 
domain.  The adapter protein Fas-associated protein with death domain (FADD) 
(Chinnaiyan et al., 1995) has both a C-terminal DD and a N-terminal death-effector 
domain (DED) which allows it to interact with the DED of caspase 8 
(MACH/FLICE/Mch5) (Boldin et al., 1996; Fernandes-Alnemri et al., 1996; Muzio 
et al., 1996).  Fas receptor activation thus induces the formation of a complex of 
proteins which was termed the death-inducing signalling complex (DISC) (Kischkel 
et al., 1995).  The formation of the DISC itself leads to activation of caspase-8 
(Medema et al., 1997; Ashkenazi and Dixit, 1999).  Interestingly caspase-10 is also 
recruited to the DISC although its role in induction of apoptosis is less clear (Wang 
et al., 1999; Kischkel et al., 2001; Sprick et al., 2002).  Several other proteins have 
been shown to be recruited to the DISC including Daxx, FAP-1, FLASH, RIP, FAF1 
and Dap3 but their role at present is unclear (Peter and Krammer, 2003). 
Another protein with a DED, which has several names including FLIP, Casper and 
CASH, has been discovered (Bertin et al., 1997; Goltsev et al., 1997; Hu et al., 1997; 
Inohara et al., 1997; Irmler et al., 1997; Shu et al., 1997; Srinivasula et al., 1997; 
Thome et al., 1997; Rasper et al., 1998).  The γ-herpesviruses express a viral 
inhibitor, viral-FLICE - like inhibitory protein (v-FLIP) which was found to 
associate with Fas in the DISC but it inhibited apoptosis (Bertin et al., 1997; Hu et 
al., 1997; Thome et al., 1997).  Subsequently its cellular homologue termed c-FLIP 
was identified (Goltsev et al., 1997; Inohara et al., 1997; Irmler et al., 1997; Shu et 
al., 1997; Srinivasula et al., 1997; Rasper et al., 1998); it has both a short and a long 
form (c-FLIPS and c-FLIPL).  Both forms have tandem DED but c-FLIPL also has a 
domain which is homologous to the caspase-8 protease death domain however in c-
FLIPL this domain has mutations which render it inactive.  It would appear that c-
FLIPL is pro-apoptotic at low concentrations but inhibitory at high levels of 
expression (Peter and Krammer, 2003).  However c-FLIPS appeared to be only 
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inhibitory; its upregulation is associated with the development of resistance to Fas-
mediated apoptosis in T-cells (Kirchhoff et al., 2000).  It has also been suggested that 
c-FLIP may activate the NF-κB and extracellular signal related kinase (ERK) 
pathway (Kataoka et al., 2000). 
We have used pharmacological inhibitors of these signal transduction pathways to 
examine the mechanisms by which the Fas/FasL pathway induces apoptosis in 
neutrophils and the mechanisms by which the inflammatory mediators, especially 




4.2.1 Inflammatory mediators and signalling pathways 
The inflammatory mediators, LPS, fMLP and GM-CSF, can prime or activate 
neutrophils (Gougerot-Podicalo et al., 1996).  LPS (0.1µg/ml), fMLP (10ng/ml) or 
GM-CSF (50U/ml) had no effect on spontaneous neutrophil apoptosis in vitro at 3 
hours (figure 4.1a).  However when neutrophils were cultured in vitro for 20 hours, 
LPS (0.1µg/ml) (36.9 + 2.7%) and GM-CSF (50U/ml) (45.7 + 3.6%) delayed 
neutrophil apoptosis (control, 71.6 + 4.3%, p<0.01), while fMLP (10ng/ml) (79.1 + 
5.5%) had no significant effect on neutrophil apoptosis (control, 68.9 + 5.3%).  At 3 
hours, all three inflammatory mediators, LPS (0.1µg/ml) (5.8 + 1.4), fMLP 
(10ng/ml) (4.2 + 0.9) and GM-CSF (50U/ml) (4.3 + 0.8) attenuated CH-11- induced 
apoptosis (20.3 + 3.2, n=3, p<0.001)(figure 4.1a). 
4.2.2 The mitogen-activated protein kinase pathway 
The p38 MAPK and p42/p44 ERK pathways are involved in intracellular signal 
transduction in neutrophils in response to LPS, fMLP and GM-CSF (Nick et al., 
1996; Nick et al., 1997; Nolan et al., 1999; Villunger et al., 2000).  PD98059 at a 
concentration of 50µM is a selective p42/p44 ERK inhibitor (Alessi et al., 1995) 
while SB203580 at 10µM is a selective competitive inhibitor of the ATP-binding site 
on p38 MAPK (Cuenda et al., 1995; Young et al., 1997).  PD98059 (50µM) had no 
effect on CH-11 induced apoptosis or on the LPS, fMLP or GM-CSF- mediated 
attenuation of CH-11- induced apoptosis (figure 4.1b).  Initial results suggested that 
SB203580 (20µM) had no effect on the LPS, fMLP or GM-CSF- mediated 
attenuation of CH-11- induced apoptosis but SB203580 (11.2 + 1.5%) attenuated 
CH-11- induced apoptosis (20.3 + 3.2%, n=3, p<0.001) (fig 2a) suggesting that CH-
11 may signal through the p38 MAPK pathway.  However this was not reproducible; 
a fresh batch of SB203580 (54 + 2.0%) augmented CH-11  induced apoptosis (50.6 
+ 1.6%, n=3, p<0.05) and SB203580 also partially reversed the LPS-mediated 
attenuation of CH-11  induced apoptosis (control, 7.1 + 0.7%; SB203580, 13.5 + 
0.7%, n=3, p<0.001) (figure 4.2b).  The initial inhibition by SB203580 may have 
been due to contamination with endotoxin as it was an older batch.  It has been 
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suggested that 20µM SB203580 also inhibits the JNK pathway whereas 5µM is 
specific for p38 MAPK (Cuenda et al., 1995).  We therefore repeated the experiment 
and found that 5µM SB203580 had no significant effect on CH-11  induced 
apoptosis (control, 39.2 + 7.7%; SB203580, 44.9 + 5.5%) but partially inhibited the 
LPS-mediated attenuation of CH-11  induced apoptosis (control 5.4 + 1.1%, 
SB203580 9.1 + 0.7%, n=3, p<0.05).  In the neutrophil, the p38 MAPK may 
therefore be involved in LPS signalling while the JNK pathway may be an anti-
apoptotic pathway; further investigation is required. 
4.2.3 The phosphatidylinositol 3-kinase pathway 
The role of PI 3-kinase in CH-11  mediated neutrophil apoptosis is not clear.  
LY294002 is a reversible, ATP-competitive inhibitor of recombinant PI 3-kinase 
(Vlahos et al., 1994).  The IC50 for inhibition of PI 3-kinase by LY294002 is 10µM 
therefore this concentration was used (Davies et al., 2000).  We have shown that 
when neutrophils were cultured for 3 hours, LY294002 had no significant effect on 
spontaneous, CH-11-induced apoptosis or on the LPS-mediated attenuation of CH-11 
 induced apoptosis (figure 4.3a).  In neutrophils, the PI 3-kinase pathway is 
involved in GM-CSF signalling (Vlahos et al., 1995; Klein et al., 2000; Cowburn et 
al., 2002) therefore we confirmed that LY294002 (10µM) did inhibit the GM-CSF 
mediated neutrophil survival at 20 hours (data not shown). 
4.2.4 The protein kinase C pathway 
Neutrophils have been shown to express the protein kinase C (PKC) isoenzymes α, 
-β, -δ ((Majumdar et al., 1991; Smallwood and Malawista, 1992) and ζ (Dang et al., 
1995).  However PKC-δ alone appears to be involved in the induction of spontaneous 
neutrophil apoptosis (Pongracz et al., 1999).  Ro318220 at 1µM is a broad-spectrum 
PKC inhibitor (Davis et al., 1992; Davies et al., 2000).  Ro318220 (1µM) accelerated 
CH-11- induced neutrophil apoptosis (CH-11, 44.6 + 8.9%; Ro318220 and CH-11, 
64.3 + 4.9%; n=3, p<0.05) and partially inhibited the LPS-mediated attenuation of 
CH-11- induced apoptosis (LPS.CH-11, 7.1 + 1.1%; Ro318220 and LPS.CH-11, 
44.2 + 6.7%; n=3, p<0.001) (figure 4.3bi).  This suggested that the PKC pathway 
was anti-apoptotic and that the inhibitory effect of LPS on neutrophil apoptosis was 
partially mediated by the PKC pathway.  We therefore investigated the effects of the 
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specific isoenzyme inhibitors; Gö6976 (10nM) inhibits the classical PKC isoenzymes 
-α, -β and -γ (Thorp et al., 1996) and Rottlerin (5µM) inhibits PKCδ (Gschwendt et 
al., 1994).  Rottlerin attenuated CH-11- induced apoptosis (control, 46 + 9.8%; 
Rottlerin, 27.1 + 11.7%; n=3, p<0.05) while Gö6976 had no effect (figure 4.2bii).  
However, neither Rottlerin nor Gö6976 had an effect on the LPS-mediated 
attenuation of CH-11- induced apoptosis (figure 4.2bii). 
4.2.5 The NF-κB pathway 
The inflammatory mediators, LPS, fMLP and TNF-α activate NF-κB in the 
neutrophil (McDonald et al., 1997).  Since IκB-α degradation is required for NF-κB 
translocation to the nucleus, we investigated the cytoplasmic protein levels of IκBα, 
in neutrophils, in response to inflammatory mediators and anti-Fas antibody, CH-11.  
At 30 minutes, LPS induced IκBα degradation whilst CH-11, fMLP and GM-CSF 
had no effect (figure 4.3a).  It has been shown that GM-CSF stimulation of 
neutrophils does not induce IκBα degradation at any time point up to 2 hours and 
fMLP only induces IκBα degradation after 60 minutes (McDonald et al., 1997).  CH-
11 had no effect on IκBα degradation when neutrophils were cultured for up to three 
hours (data not shown). 
Our group has shown that the prostaglandin D2 (PGD2) metabolite 15-deoxy-∆12, 
∆14-PGJ2 (15dPGJ2) at a concentration of 10µM inhibits both LPS-mediated IκBα 
degradation in the neutrophil and the LPS-mediated survival effect on neutrophil 
apoptosis (Ward et al., 2002).  We thus proposed that 15dPGJ2 would also inhibit the 
LPS-mediated attenuation of CH-11 - induced apoptosis.  However as 15dPGJ2 also 
activates perioxisome proliferating activating receptor-γ (PPAR-γ) (Jiang et al., 
1998; Ricote et al., 1998), the specific PPAR-γ agonist ciglitazone (10µM) was used 
to determine if the LPS-mediated attenuation of CH-11- induced apoptosis involved 
the PPAR-γ pathway.  Gliotoxin is also a potent and specific inhibitor of NF-κB 
(Pahl et al, 1996).  We have shown that 15dPGJ2 (29.7 + 8.8%) partially inhibited the 
LPS-mediated attenuation of CH-11- induced apoptosis (6.3 + 2.5%, p>0.05) while 
ciglitazone had no effect (figure 4.4b).  Furthermore, neither 15dPGJ2 nor ciglitazone 
affected CH-11- induced apoptosis (figure 4.4b).  Due to the formation of the DISC 
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in the death receptor pathways, caspase-8 which is produced as a proenzyme (55/50 
kDa doublet) is cleaved into smaller subunits of 40/36 kDa (doublet) and 23 kDa 
(Medema et al., 1997). We showed that CH-11 and TNF-α/Gliotoxin induced 
caspase-8 degradation in neutrophils (figure 4.4c).  The induction of caspase-8 
degradation by CH-11 was inhibited by LPS and this LPS-mediated inhibition was 
reversed by 15dPGJ2 (figure 4.4c). 
4.2.6 Expression of c-FLIP in the neutrophil 
Our data suggest that the inhibitory effect of LPS on CH-11- induced apoptosis is 
associated with inhibition of caspase 8 degradation.  Furthermore, pre-incubation 
with CH-11 reversed the anti-apoptotic effect of LPS (figure 4.5a).  This raised the 
possibility that the inhibitory effect of LPS on CH-11- induced apoptosis may be 
mediated by the protein c-FLIP at the level of the DISC (diagram 4.2).  Neutrophils 
constitutively expressed the 22kDa protein cFLIPs but did not express the 55kDa 
protein cFLIPL (figure 4.5b).  Furthermore, the anti-FLIP antibody appeared to bind 
to a second protein which is approximately 24kDa and this protein may represent 
cFLIPs which has been post-translationally modified.  After 15 minutes incubation, 
the 24kDa cFLIPs appeared to be degraded however autologous serum appeared to 
inhibit this degradation.  LPS, at the concentration used in these experiments 
(0.1µg/ml), requires the lipopolysaccharide binding protein (LBP) found in serum, 
for its activity.  Thus active LPS (LPS and Fbs) and fMLP appear to augment the 
levels of both the 22 and 24kda forms of cFLIPs at this time point (figure 4.5b).  The 
quantity of protein in each sample is demonstrated by reprobing the blot for β-actin 
protein levels (figure 4.5c).  The function of cFLIPs in the neutrophil is not known. 
4.2.7 A strategy to immunoprecipitate the DISC and any other bound proteins 
In order to investigate regulation of neutrophil apoptosis at the level of the DISC, we 
devised a strategy to use the cytoplasmic tail of the Fas receptor tagged to biotin to 
go fishing for proteins which bind to the Fas receptor in lysates of control 
neutrophils and LPS-stimulated neutrophils.  The biotin tagged proteins could then 
be immunoprecipitated using streptavidin beads (diagram 4.3). 
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The first part of this approach involved making the fishing rod.  The cloned Fas 
receptor was obtained in the pCMV.Sport6 plasmid from LGC Promochem, UK 
(diagram 4.4a).  Firstly we checked that the plasmid contained the Fas Receptor; 
using hind III restriction enzymes (diagram 4.4), we showed that the product 
obtained was the expected size 1342 base pairs (figure 4.6a).  Using PCR (with the 
primers shown in diagram 4.5b), DNA encoding the cytoplasmic tail of the Fas 
receptor was produced.  The DNA was then ligated into the Pinpoint Xa vector using 
the PinpointTM Xa-1 T-Vector system (Promega, Madison, WI, USA).  The Pinpoint 
Xa vector contains DNA encoding the Biotin purification tag (diagram 4.6).  
Competent E. coli, JM109, were then transformed as described previously.  Initially 
16 colonies were sampled and using Hind III restriction enzyme digest, clone 4 
was found to contain the FasR cDNA in the correct orientation (figure 4.5b).  The 
cDNA was purified and 2µg sent to MWGBiotech for sequencing.  The cloned 
sequence was verified as described in the methods. Protein production, by the 
transformed E. coli JM109 colonies grown up in Luria-Bertani broth, was induced by 
adding isopropyl β-D-thiogalactopyranoside (IPTG).  The E.coli containing no insert 
expressed a protein of 13kDa, those containing control cDNA expressed a protein of 
27kDa and clone 4 E.coli containing the FasR insert expressed a protein of 32kDa 
(figure 4.6a).  The transformed E.coli were then cultured on a larger scale and 
induced to produce the biotinylated protein.  The bacteria were then lysed using the 
lysozyme and detergent method although some biotinylated protein was lost and 
detected in the lysed bacterial cell pellet (figure 4.7bi).  The bacterial cell lysate was 
applied to the prepared SoftLink monomeric avidin column and a sample of the 
flow-through showed that there was good binding of the biotinylated protein to the 
column (figure 4.7bii).  Although the 1ml eluate contained 110µg protein there was 
significant degradation of the protein in the purification process and a large amount 
of the protein remained bound to the column (figure 4.7bii).  Future work would 
involve transformation of a different E.coli strain (BL21) which is deficient in 
proteases.  This may overcome the degradation problem and batch purification may 




The neutrophil is a professional phagocyte however in the absence of bacterial 
infection and at sites of inflammation, its lifespan is regulated by factors within the 
inflammatory milieu.  If the neutrophils lifespan is prolonged such that it undergoes 
secondary necrosis, this will exacerbate tissue injury.  A strategy, used 
therapeutically in drug development, targets the signalling pathways used by these 
inflammatory mediators.  We have explored these signalling pathways in human 
neutrophils particularly investigating those utilised by lipopolysaccharide (LPS) and 
the Fas/FasL pathway. 
We, and others, have shown that inflammatory mediators including LPS and GM-
CSF, not only prolong neutrophil survival in vitro, they also attenuate Fas-mediated 
neutrophil apoptosis (Colotta et al., 1992; Lee et al., 1993; Liles et al., 1996).  The 
LPS used in these studies was not purified therefore will contain a significant amount 
of bacterial lipopeptide (Hirschfeld et al., 2000).  The LPS will therefore signal 
through both TLR2 and TLR4 receptors on the neutrophil.  Furthermore during the 
process of neutrophil extraction from whole blood, contaminating monocytes were 
not removed by negative selection.  It has now been shown that purified LPS (a 
TLR4 agonist) also delays early constitutive apoptosis of purified neutrophils 
(Sabroe et al., 2003).  The mediator, fMLP had no effect on early (4h) or late (20h) 
spontaneous neutrophil apoptosis but attenuated Fas-induced neutrophil apoptosis.  
Protein kinases are differentially activated by inflammatory mediators.  While fMLP 
has been shown to activate p42/44 ERK and p38 MAPK (Nick et al., 1997), GM-
CSF strongly activated the ERK cascade and PI 3-kinase pathway (Klein et al., 2000; 
Cowburn et al., 2002).  However, we have shown that the p42/44 ERK pathway was 
not involved in the fMLP and GM-CSF-mediated attenuation of CH-11- induced 
apoptosis. 
Early spontaneous and Fas-mediated neutrophil apoptosis appears to be independent 
of p38 MAPK.  At a later time point (12 hours), other investigators have shown that 
the p38 MAPK inhibitor, SB203580, augments spontaneous and Fas-induced 
apoptosis; phosphorylated p38 MAPK was present constitutively in human 
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neutrophils and the activity of p38 MAPK was inhibited during spontaneous and CH-
11- induced apoptosis (Alvarado-Kristensson et al., 2002).  Subsequently they have 
shown that Fas receptor stimulation results in protein phosphatase 2A (PP2A) 
activation which dephosphorylates p38MAPK and caspase 3 resulting in decreased 
p38 MAPK activity but increased caspase 3 activity and thus neutrophil apoptosis 
(Alvarado-Kristensson and Andersson, 2005).  In murine neutrophils, SB203580 also 
accelerated spontaneous neutrophil apoptosis (Villunger et al., 2000).  Other groups 
have found differing results; Aoshiba et al (1999) found that SB203580 delayed 
spontaneous neutrophil apoptosis but had no effect on Fas-induced apoptosis.  
Furthermore, the p38 MAPK inhibitor SKF-86002, had no effect on spontaneous or 
Fas-induced apoptosis (Frasch et al., 1998) however this inhibitor appears be less 
specific for p38 MAPK, also activating cyclooxygenase and 5-lipoxygenase 
(Griswold et al., 1987).  
LPS has been shown to prolong neutrophil survival however this effect was not 
apparent at early time points (4 hours).  Our group and others have shown that this 
survival effect is partially mediated by p42/44 ERK (Nolan et al., 1999; Klein et al., 
2001; Ward et al., 2005).  At early time points, the p42/44 ERK inhibitor, PD98059, 
had no effect on spontaneous or LPS-mediated neutrophil apoptosis.   
The role of p38 MAPK in LPS-mediated neutrophil survival is less clear.  LPS has 
been shown to activate the α-isoform of p38 MAPK resulting in neutrophil adhesion, 
NF-κB stimulation and TNF-α synthesis (Nick et al., 1999). However two studies 
have shown LPS-mediated survival to be independent of p38 MAPK (Klein et al., 
2001; Ward et al., 2005) and a third study confirmed that LPS activated p38 MAPK 
but showed that it was pro-apoptotic (Nolan et al., 1999).  Furthermore, we have 
shown, at early time points, that 5µM and 20µM SB203580 partially reversed the 
LPS mediated attenuation of CH-11 - induced apoptosis suggesting that p38 MAPK 
mediates an anti-apoptotic pathway.  The inhibitor SB203580 at higher 
concentrations (20µM) also inhibits the JNK pathway (Cuenda et al., 1995).  It has 
been proposed, in human neutrophils, that JNK pathway activation, upon LPS 
stimulation, depends upon the physiological state of the neutrophil; in suspended 
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neutrophils LPS does not activate JNK (Nick et al., 1999) however in adherent 
neutrophils JNK is activated (Arndt et al., 2004). 
The PI 3-kinase pathway is important in mediating the survival effect of GM-CSF in 
neutrophils.  However at early time points it was not involved in LPS or Fas 
signalling (figure 4.4a).  At later time points, LY294002 (10µM) reversed the 
survival effect of LPS (Ward et al., 2005) and in murine PI 3 kinase-/- neutrophils 
both basal and LPS-stimulated cells showed increased rates of apoptosis compared to 
the wild type (Yang et al., 2003).  Although PI 3-kinase is usually considered an 
anti-apoptotic pathway in neutrophil biology, in one study LY294002 had no effect 
on LPS-mediated survival (Klein et al., 2001) and another group have shown that 
LY294002 inhibited CH-11-induced apoptosis at later time points (Alvarado-
Kristensson et al., 2002). 
The protein kinase C (PKC) pathway, in particular the PKCδ isoenzyme has been 
implicated in both spontaneous and Fas-induced neutrophil apoptosis (Khwaja and 
Tatton, 1999; Pongracz et al., 1999).  The PKC inhibitor, Ro318220(1µM), not only 
augmented spontaneous and CH-11- induced apoptosis, it also partially reversed the 
LPS-mediated attenuation of CH-11- induced apoptosis.  However, the specific 
PKCδ inhibitor, Rottlerin significantly attenuated CH-11 induced apoptosis but had 
no effect on the LPS-mediated attenuation.  These inhibitors have subsequently been 
shown to inhibit many protein kinases and therefore valid conclusions cannot be 
drawn from these data alone (Davies et al., 2000).  Other groups have shown that the 
protein kinase C pathway is important in spontaneous and Fas-induced neutrophil 
apoptosis by demonstrating that in the former, caspase 3 and in the latter, caspase 8 
mediate PKCδ cleavage and activation (Khwaja and Tatton, 1999; Pongracz et al., 
1999).  
The NF-κB family of transcription factors mediate many of the cellular responses to 
inflammatory mediators.  In the neutrophil, the prototypic TNF-α death receptor 
pathway induces both death in the neutrophil via the caspases and life via NF-κB 
activation (Ward et al., 1999).  In the neutrophil, LPS also activate NF-κB through 
p38 MAPKα (Nick et al., 1999) (diagram 4.2).  Furthermore in cell lines, both 
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sensitive and resistant to apoptosis induced by Fas ligation, anti-CD95 antibody 
activated NF-κB (Ponton et al., 1996).  In human bronchiolar epithelial cells and 
monocytes, Fas ligation has also been associated with NF-κB activation (Hagimoto 
et al., 1999; Park et al., 2003)  However in human neutrophils we have shown that 
while LPS induced IκBα degradation, CH-11 had no effect.  Thus Fas ligation in the 
neutrophil does not activate NF-κB.  The cytoplasmic adapter protein FLIP is 
thought to be important in regulating the apoptotic/non-apoptotic switch at the level 
of the DISC (Wajant et al., 2003).  In endothelial cells, cellular FLIP appears to 
protect against LPS-induced apoptosis and suppresses NF-κB activation (Bannerman 
D et al, 2004). We have shown that neutrophils only express the short form of 
cellular FLIP (cFLIPS) and its role at present is not clear.  
An alternative strategy looked at inhibiting the NF-κB pathway.  There are several 
natural and synthetic NF-κB inhibitors.  The PGD2 metabolite 15dPGJ2 is known to 
inhibit LPS-mediated IκBα degradation (Ward et al., 2002).  We found that 15dPGJ2 
partially inhibited the LPS-mediated attenuation of CH-11  induced apoptosis and 
this was associated with 15dPGJ2 partially inhibiting the LPS-mediated attenuation 
of caspase-8 degradation.  Furthermore at early time points, the cellular 
concentration of cFLIPS was differentially regulated by LPS and CH11.  Our data 
suggested that LPS inhibited Fas signalling in the human neutrophil at the level of 
the DISC.  We therefore devised a strategy to determine the proteins which bind to 
the cytoplasmic tail of the Fas receptor upon Fas ligation and to determine if this 
protein binding is altered by LPS.  Initially DNA encoding the cytoplasmic tail of the 
Fas receptor was cloned into the Pinpoint Xa vector in order to produce a biotin-
tagged protein.  The 32kDa biotin-tagged Fas receptor cytoplasmic tail was 
successfully produced however we were subsequently unable to batch purify the 
protein without significant proteolytic breakdown.  Other investigators have 
subsequently managed to immunoprecipitate the neutrophil DISC using anti-Fas 
receptor monoclonal antibodies (Apo-1 and Fas B-10)  and protein A/G (Daigle et 
al., 2002; Scheel-Toellner et al., 2004).  This alternative strategy could therefore be 
utilised to examine the effects of LPS on the Fas signalling pathway. 
Chapter 4 
 80
We have shown that pre-incubation with GM-CSF inhibits Fas-mediated apoptosis: 
conversely GM-CSF-mediated survival is inhibited by simultaneous activation of the 
Fas receptor (Daigle et al., 2002).  Elegant studies have shown that the Fas receptor 
death domain contains a tyrosine residue which upon phosphorylation binds the 
inhibitory phosphatase Src homology domain 2 (SH-2)-containing tyrosine 
phosphatase-1 (SHP-1).  As previously described GM-CSF stimulates anti-apoptotic 
pathways which include tyrosine phosphorylation of Lyn; this is prevented by 
concurrent Fas receptor ligation and it is proposed that SHP-1 mediates this 
inactivation (Daigle et al., 2002).  On the other hand, pre-incubation with GM-CSF 
has been shown to interfere with the recruitment of FADD to the DISC upon Fas 
receptor ligation (Kotone-Miyahara et al., 2004). 
Thus the regulation of neutrophil lifespan is complex depending not only on factors 
within the inflammatory milieu but within the cell itself, there is cross-talk between 
















Figure 4.1. The p42/44 ERK pathway, CH-11, inflammatory mediators and 
neutrophil apoptosis 
 
(a) Effect of LPS, fMLP and GM-CSF on spontaneous and CH-11 induced neutrophil 
apoptosis. Neutrophils (5 x 106/ml) in Pbs and 10% Fbs were pre-incubated in a shaking 
water bath for 1 hour with LPS (0.1µg/ml), fMLP (10ng/ml) or GM-CSF (50U/ml).  They 
were then incubated for a further 3 hours in flexible well plates with CH-11 (500ng/ml) and 
apoptosis was assessed by Annexin V binding. * p<0.01 compared with CH-11 control 
values.  (b) The effect of pre-incubation with PD98059 (50µM) on the LPS, fMLP and GM-
CSF attenuation of CH-11 induced apoptosis. Neutrophils (5 x 106/ml) in Pbs were pre-
incubated for 1 hour in a shaking water bath with Pbs or PD98059 (50µM). They were then 
incubated for a further 3 hours in flexible well plates with 10% Fbs and either Pbs + CH-11 
(500ng/ml), LPS (0.1µg/ml) + CH-11 (500ng/ml), fMLP (10ng/ml) + CH-11 (500ng/ml) or 
GM-CSF (50U/ml) + CH-11 (500ng/ml).  Apoptosis was assessed by Annexin V binding.  







































































Figure 4.2. The p38 MAPK pathway, CH-11, inflammatory mediators and 
neutrophil apoptosis 
 
(a) The effect of pre-incubation with SB203580 (20µM) on the LPS, fMLP and GM-CSF- 
mediated attenuation of CH-11 induced apoptosis. Neutrophils (5 x 106/ml) in Pbs were pre-
incubated for 1 hour in a shaking water bath with Pbs or SB203580 (20µM). They were then 
incubated for a further 3 hours in flexible well plates with 10% Fbs and either Pbs + CH-11 
(500ng/ml), LPS (0.1µg/ml) + CH-11 (500ng/ml), fMLP (10ng/ml) + CH-11 (500ng/ml) or 
GM-CSF (50U/ml) + CH-11 (500ng/ml).  Apoptosis was assessed by Annexin V binding.  
(b) The effect of pre-incubation with a new batch of SB203580 (20µM) on the LPS  
mediated attenuation of CH-11 induced apoptosis.  Neutrophils (5 x 106/ml) in Pbs were pre-
incubated for 1 hour in a shaking water bath with Pbs or SB203580 (20µM). They were then 
incubated for a further 3 hours in flexible well plates with 10% Fbs and either Pbs + CH-11 
(500ng/ml) or LPS (0.1µg/ml) + CH-11 (500ng/ml).  Apoptosis was assessed by Annexin V 
binding.  All values represent mean + SEM of n = 3 experiments; each performed in 















































































Figure 4.3. The PI3-K/PKC pathway, CH-11, LPS and neutrophil apoptosis 
 
The effect of pre-incubation with (a) the PI3-kinase inhibitor, LY294002, (bi) the PKC 
inhibitor, Ro318220, (bii) the PKCδ inhibitor, Rottlerin and PKC (classical isoenzyme) 
inhibitor, Go6976 on the LPS-mediated attenuation of CH-11 - induced apoptosis.  
Neutrophils (5 x 106/ml) in PBS were pre-incubated for 1 hour in a shaking water bath with 
PBS or (a) LY294002 (10µM) or (bi) Ro318220 (1µM) or (bii) Rottlerin (5µM), Go6976 
(10nM). They were then incubated for a further 3 hours in flexible well plates with 10% FBS 
and either PBS, CH-11 (500ng/ml), LPS (0.1µg/ml) or LPS (0.1µg/ml) and CH-11 
(500ng/ml).  Apoptosis was assessed by Annexin V binding.  All values represent mean + 


























































































Figure 4.4. The NF-κB pathway and neutrophil apoptosis 
 
(a) IκBα protein in neutrophils. Neutrophils (5 x 106/ml) in Pbs and 10% Fbs were incubated 
in a shaking water bath with PBS, LPS (0.1µg/ml), fMLP (10ng/ml), GM-CSF (50U/ml) or 
CH-11 (500ng/ml) for 30 minutes.  Cell lysates were prepared and Western blotting carried 
out using IκBα antibody (1:500). (b) Effect of the prostaglandin D2 metabolite, 15-deoxy-∆12, 
∆14- PGJ2 (15dPGJ2) on LPS-mediated attenuation of CH-11- induced neutrophil apoptosis.  
Neutrophils (5 x 106/ml) in Pbs were pre-incubated in a shaking water bath with 15dPGJ2 
(10µM) and ciglitazone (10µM) for 1 hour.  They were then incubated for a further 3 hours 
in flexible well plates with 10% FBS and either PBS, CH-11 (500ng/ml), LPS (0.1µg/ml) or 
LPS (0.1µg/ml) and CH-11 (500ng/ml).  Apoptosis was assessed by Annexin V binding. (c) 
Caspase 8 protein in neutrophils. Neutrophils (5 x 106/ml) in Pbs were pre-incubated in a 
shaking water bath for 30 min with Pbs or 15dPGJ2 (10µM). They were then incubated for a 
further 4 hours with 10% Fbs and either Pbs, CH-11 (500ng/ml) or LPS (0.1µg/ml) and CH-
11 (500ng/ml). Neutrophils (5 x 106/ml) in Pbs and 10% Fbs were incubated in a shaking 
water bath for 2 hours with TNF-α (10ng/ml) and gliotoxin (Glio) (2µg/ml). Cell lysates 
were prepared and Western blotting carried out using caspase-8 antibody (4µg/ml). 
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Cont        CH11   LPS.CH11   15dPGJ2        TNF






























































Figure 4.5. cFLIP, CH-11, inflammatory mediators and neutrophil apoptosis 
 
(a) The effect of pre-incubation with CH-11.  Neutrophils (5 x 106/ml) in Pbs and 10% Fbs 
were incubated in a shaking water bath with LPS (0.1µg/ml) or CH-11 (500ng/ml) for 60 
minutes. They were then incubated for a further 3 hours in flexible well plates with either 
CH-11 (500ng/ml) or LPS (0.1µg/ml).  Apoptosis was assessed by Annexin V binding.  All 
values represent mean + SEM of n = 3 experiments; each performed in duplicate. *p<0.01. 
(b) The effect of serum, anti-Fas antibody (CH-11) and inflammatory mediators on cFLIP 
protein levels in human neutrophils.  Neutrophils (5 x 106/ml) in Pbs + 10% Fbs or 10% 
autologous serum (As) were incubated in a shaking water bath for 15 min with CH-11 
(500ng/ml) or LPS (0.1µg/ml) or fMLP (10ng/ml).  Cell lysates were prepared and Western 
blotting carried out using (bi) anti-human FLIP (1:1000).  (bii) The blot was stripped and 
reprobed with anti-human β-actin (1:100).  
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Figure 4.6. Hind III restriction digest of cDNA 
 
(a) Hind III restriction digest of purified pCMV.Sport6 vector containing Fas receptor 
cDNA.  The predicted size of the linearised plasmid is 5808bp and the Fas receptor insert is 
1342bp (diagram 4.4).  (b) Hind III restriction digest of cDNA purified from transformed 
JM109 cells. The predicted size of the product is 451bp (diagram 4.6).  In lane 3, using PCR 
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Figure 4.7. Biotinylated Fas protein expression 
 
(a) Expression of biotinylated proteins by transformed E.Coli JM109.  E.Coli JM109 were 
transformed with PinpointTM Xa plasmid containing no insert, control DNA supplied by 
Promega and the FasR cytoplasmic tail DNA (clone 4, figure 4.6) and grown up in Luria-
Bertani broth.  Cell lysates were prepared and Western blotting carried out using HRP-
Streptavidin (1:2500).  (bi) E.Coli JM109 transformed with PinpointTM Xa plasmid 
containing FasR cytoplasmic tail DNA (+ve, lane 1) and no insert (-ve, lane 2) were cultured 
on a large scale having been induced with IPTG to produce protein (lanes 3 and 4).  The 
bacteria were lysed using lysozyme and detergent (lane 5) and cell debris pelleted (lane 6). 
Western blotting of the samples was carried out using HRP-Streptavidin (1:2500).  (bii) 
Protein purification using the SoftLink monomeric avidin resin column.  The lysate (lane 
1) was applied to the column and a sample of the flow-through collected (lane 2).  The 
protein was then eluted (lane 3) from the column (lane 4).  Western blotting of the samples 
was carried out using HRP-Streptavidin (1:2500). 
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Diagram 4.1. The prostaglandin (PG) pathway 
 
Prostaglandins are primarily derived from arachidonate which phospholipases release from 
membrane phospholipids.  Arachidonate is converted to an unstable intermediate PGG2 by 
cyclooxygenase (COX).  This is subsequently converted by specific prostaglandin 
synthetases to PGD2, PGE2, PGF2α, prostacylin (PGI2) and thromboxane A2 (TxA2).  In vitro, 
PGD2 spontaneously converts into the cyclopentone prostaglandins of the J series, PGJ2, ∆12- 


































Diagram 4.2. Schematic diagram depicting proposed signalling pathway by 
which LPS inhibits the Fas receptor pathway in human neutrophils. 
 
LPS binds to a TLR4-MD-2 complex which transduces the signal intracellularly.  The 
cellular receptor, CD14 amplifies this signal (Miyake, 2004).  Furthermore a serum 
component, LPS-binding protein, enhances the binding of LPS to CD14 (Wright et al., 
1990).  This leads to the activation of the MKK3/p38αMAPK cascade which results in NF-
κB activation.  The pathway upstream of MKK3 (MEKK-X) is not yet known (Nick et al., 
1999).  The binding of FasL to Fas results in trimerization/oligomerization of the receptor 
and recruitment of the adaptor protein Fas-associated death domain containing protein 
(FADD) and caspase-8 to form the death-inducing signalling complex (DISC) (Kischkel et 
al., 1995) which in turn initiates the caspase cascade resulting eventually in activation of the 


























































Diagram 4.3. Schematic diagram of the proposed experiment using a Fas 
receptor cytoplasmic tail tagged with biotin to discover what human neutrophil 
proteins bind to the cytoplasmic tail. 
 
In this proposed experiment, neutrophils would be incubated for 4h under control conditions 
and stimulated with LPS.  Cell lysates would then be prepared as described in the methods.  
Fas receptor stimulation results in the cytoplasmic tail forming a death-inducing signalling 
complex (DISC).  It is proposed that when the cells are stimulated with LPS the binding of 
cFLIPs or other survival protein(s) to the DISC is differentially regulated.  The biotin-
tagged proteins would then be immunoprecipitated using streptavidin-coated magnetic 
beads. 




















































Diagram 4.4. The pCMV.Sport6 plasmid and cloned Fas receptor 
 
(a) pCMV-Sport 6 vector map. (b) Schematic representation of human Fas receptor DNA.  
The open box represents the open reading frame within which the small box indicates the 










































Diagram 4.5. The cytoplasmic tail of the human Fas receptor 
 
(a) Schematic representation of the 436bp cytoplasmic tail of the human Fas receptor 
(GenBank: NM_000043) with a Hind III restriction enzyme site at 423bp. (b) The sequence 
of the cytoplasmic tail of the human Fas receptor (Itoh et al, 1991).  The primer sequences 








































































Diagram 4.6. Schematic representation of DNA ligation into the PinpointTM Xa 
vector 
 














The Macrophage and Neutrophil Apoptosis 
 
5.1 Introduction 
Lipopolysaccharide (LPS) is a common infectious trigger in the human lung and its 
action is utilized in animal models of acute lung injury.  LPS activates macrophages 
to produce cytokines however the cytokine milieu differs depending on the 
inflammatory trigger (Lucas et al., 2003). 
In addition to cytokines and other inflammatory mediators, the Fas-Fas ligand 
pathway may also be important at sites of inflammation.  Monocytes and 
macrophages constitutively express the Fas receptor (Liles et al., 1996; Kiener et al., 
1997; Kiener et al., 1997).  Mononuclear cells have mRNA for FasL (figure 3.5) and 
upon activation T-lymphocytes and monocytes express FasL (Kiener et al., 1997; 
Bossi and Griffiths, 1999).  Macrophages do not constitutively express FasL however 
when they phagocytose opsonized zymosan or apoptotic neutrophils, its surface 
expression is induced (Brown and Savill, 1999).  Furthermore sFasL was found in 
the supernatants from these stimulated macrophages and these conditioned 
supernatants also induced apoptosis in neutrophils (Brown and Savill, 1999). 
However the cytokine milieu produced by macrophages differs depending whether 
particulates or effete cells have been phagocytosed.  When macrophages 
phagocytosed latex beads although the conditioned supernatant contained sFasL, it 
was unable to induce apoptosis in neutrophils.  Furthermore the pro-apoptotic 
activity of the conditioned supernatant from macrophages which have phagocytosed 
apoptotic neutrophils was only partially due to sFasL (Brown and Savill, 1999). 
We have further explored the soluble factors produced by LPS-activated 




Initially the experimental conditions were optimized using the monocytic cell line 
THP-1. 
5.2.1 THP-1 and neutrophil co-culture 
The THP-1 cells are derived from the peripheral blood of a 1 year old male with 
acute monocytic leukaemia (European Collection of Cell Cultures).  They are grown 
in suspension but can differentiate into a macrophage phenotype using fibronectin 
and phorbol 12-myristate 13-acetate (PMA) (Auwerx, 1991).  As PMA can trigger 
degranulation of neutrophils (Dewald et al., 1983), after 24 hours, the differentiated 
THP-1 cells were washed and grown for a further 24 hours in fresh medium (RPMI 
and 10% FBS).  The cells were activated with differing concentrations of LPS (0.01, 
0.1 and 1µg/ml) however no difference in activity of the conditioned media was seen.  
The cells were therefore stimulated with LPS (1µg/ml). 
Initially the cells were stimulated with LPS for 4 hours.  When neutrophils (PMN) 
were co-cultured with LPS-activated THP-1 cells, there was a non-significant trend 
suggesting that activated THP-1 cells induced neutrophil apoptosis maximally (10.9 
+ 2.8%; control, 3.0 + 1.3%) in the presence of their conditioned media (figure 5.1a).  
The conditioned media alone had no effect on neutrophil apoptosis (figure 5.1a).  
When the cells were stimulated with LPS for 20 hours and apoptosis assessed after 4 
hours incubation, activated THP-1 cells, significantly and maximally, induced 
neutrophil apoptosis (7.7 + 1.2 %; control, 3.2 + 0.8%, p<0.05) in the presence of 
their conditioned media (figure 5.1b).  In the presence of conditioned media alone, 
there was a non-significant trend suggesting that it increased neutrophil apoptosis 
(5.8 + 1.1%; control, 2.8 + 0.3%).  After 8 hours incubation, THP-1 cells prolonged 
neutrophil survival (THP, 1.2 + 0.7%; PMN, 6.4 + 0.6%, p<0.01) and both LPS-
activated THP-1 cells and conditioned media alone non-significantly attenuated 
neutrophil apoptosis (figure 5.1b).  After removing the cell supernatants, the plates 
were fixed with glutaraldehyde (2.5%) and the myeloperoxidase of neutrophils 
stained with 0.1mg/ml dimethoxybenzidine (DMB) and 0.03% (v/v) hydrogen 
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peroxide.  A limitation of these experiments is that viable neutrophils did adhere to 
THP-1 cells so rates of apoptosis in co-culture experiments are probably over-
estimated however there was no evidence of phagocytosis of apoptotic neutrophils. 
5.2.2. The effect of conditioned supernatants from LPS-stimulated, human 
peripheral blood-derived macrophages (HDM) 
Human peripheral blood-derived mononuclear cells (HDMC) differentiate in vitro 
into macrophages under certain experimental conditions.  After the HDMCs 
(4x106/ml in IMDM) have been plated onto plastic tissue culture ware for 1 hour, the 
monocytes adhere such the lymphocytes can be washed off.  In the presence of 
autologous serum, over 5 days, the monocytes differentiate into macrophages (figure 
5.2b).  When the cells are stimulated with LPS (1µg/ml) for 20 hours, transfer of the 
conditioned supernatants (CM) induces neutrophil apoptosis (45 + 3.6%; control, 3.3 
+ 0.4%, p<0.001).  If the CM is fractionated through 50kD filters, neutrophil 
apoptosis is induced entirely by the fraction containing proteins with a mass greater 
than 50kD (50kD+) (46.0 + 0.7%; 50kD-, 6.1 + 1.3%, p<0.001).  CM transferred 
from unstimulated HDM did not induce neutrophil apoptosis (1.76 + 0.65%, n=3, 
data not shown) 
In order to examine the proteins which are present in the conditioned media we 
entered the field of proteomics.  We planned to utilize two techniques to maximize 
resolution of the different proteins.  The first was 2D gel electrophoresis coupled 
with mass spectrometry to determine the protein identity.  At the same time, we had 
the opportunity to utilise the newer surface-enhanced lased desorption and ionization 
 time of flight (SELDI-TOF) technique which provides rapid protein profiling 
analysis (Ciphergan).  Serum contains many soluble proteins therefore to maximize 
resolution of the proteins produced by the LPS-stimulated macrophages, we 
optimized a serum-free experiment.  Macrophage-SFM supplemented with GM-CSF 
(500U/ml) has been shown to support human peripheral blood macrophage function 
comparable to conventional serum-based media (Geissler et al., 1989; Vincent et al., 
1992).  We have shown that human peripheral blood monocytes maintained in the 
presence of serum form more giant cells however the absence of serum does not alter 
their phenotype; both serum and serum-free macrophages expressed CD64, HLA-
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DR, FcγRI and CD14 receptors on their surface (figure 5.2b).  Lipopolysaccharide-
binding protein (LBP) was required in the absence of serum to enable LPS (1µg/ml) 
to activate the HDMs such that their conditioned supernatants induced neutrophil 
apoptosis (control mean, 7.7%; CM mean 23.9%, n=2) (figure 5.3a).  The optimal 
concentration of LBP was found to be 15.9µg/ml (data not shown).  The 50kD+ CM 
fraction from serum-free HDMs was again pro-apoptotic (mean 15.5%, control 
mean, 7.7%, n=2) (figure 5.3a).  These 50kD+ and 50kD- conditioned supernatants 
were stored at -70°C.  Subsequently 2D electrophoresis of the supernatants was 
carried out as described in the methods (figure 5.3b).  Unfortunately we do not 
currently have access to automated software to comprehensively analyze the 2D gels 
but our subsequent work suggested TNF-α was important.  The supernatants were 
also sent for SELDI-TOF mass spectrometry analysis but there was a problem with 
their software and they were unable to analyse the specimens. 
Our group has previously shown that the conditioned supernatant from macrophages 
which have phagocytosed apoptotic neutrophils is able to induce apoptosis in fresh 
neutrophils (Brown and Savill, 1999).  We therefore investigated the conditioned 
media of LPS-stimulated monocyte-derived macrophages which have phagocytosed 
apoptotic neutrophils.  The cytokine content of the conditioned supernatants was 
determined using flow cytometry and a cytokine bead assay, as described in the 
methods.  LPS-stimulated macrophages produced large quantities of TNF-α (3627 + 
717 pg/ml), IL-6 (2836 + 1093 pg/ml) and IL-8 (>5000 pg/ml) (n=3, figure 5.4a).  At 
this time point (20h), macrophages which have phagocytosed apoptotic neutrophils 
produced minimal amounts of these cytokines and phagocytoses of apoptotic 
neutrophils also appears to downregulate the LPS-induced secretion of TNF-α 
(range, 6.7-18.1 pg/ml), IL-6 (range, 14.9-169.5 pg/ml) and IL-8 (range, 789.5-5000 
pg/ml) (n=2, figure 5.4a).  Furthermore, at this time point the conditioned 
supernatants from neither control monocyte-derived macrophages, which had 
phagocytosed apoptotic neutrophils nor those which had been concurrently 
stimulated with LPS and phagocytosed apoptotic neutrophils, induced apoptosis in 
freshly isolated neutrophils (figure 5.4b). 
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As there was significant production of TNF-α by the LPS-activated macrophages and 
TNF-α (EC50 2.8ng/ml) can induce apoptosis in neutrophils at early time points 
(Murray et al., 1997), we used a neutralizing anti-human TNF-α antibody to try to 
block the activity of TNF-α in the conditioned supernatants.  The concentration of 
neutralizing antibody required to block neutrophil apoptosis induced by recombinant 
human TNF-α (50ng/ml) was determined to be 3 to 30µg/ml.  Anti-TNF-α antibody 
was therefore used at a concentration of 3µg/ml in subsequent experiments (figure 
5.5a).  Neutrophil apoptosis induced by the conditioned supernatants from LPS-
stimulated monocyte-derived macrophages was completely inhibited by neutralizing 
anti-TNF-α antibody (3µg/ml) (CM, 19.3 + 3.8%; anti-TNF.CM, 1.0 + 0.5%, 
p<0.001) (figure 5.5b).  The apoptotic effect of the conditioned media was also lost 
with heating (HI) at 95°C for 5 minutes (HI.CM, 0.4 + 0.2%, p<0.001) (figure 5.5b).  
However the neutralizing anti-Fas antibody, ZB4, had no effect (figure 5.5b).  At 
early time points (4h), the conditioned supernatant induced apoptosis however at 
later time points (8h), it induced survival (figure 5.5c).  Our group has previously 
shown this temporal effect on neutrophil apoptosis with recombinant TNF-α (Murray 
et al., 1997) therefore this is consistent with our finding that neutralizing anti-TNF-α 
antibody inhibits the effect of the conditioned supernatant. 
This suggests that TNF-α is important in the induction of neutrophil apoptosis by 
LPS-stimulated monocyte-derived macrophages.  However phagocytosis of apoptotic 
neutrophils downregulates TNF-α production and in association with adoption of this 
anti-inflammatory phenotype, its conditioned supernatant was no longer able to 
induce apoptosis in bystander neutrophils.  This is likely to be important as the 
neutrophil will have to function as the main defence against infection whilst the 




It has been known for many years that macrophages are important in innate 
immunity however their role in inflammatory diseases has only recently become 
more apparent.  They appear to be central to the switch from inflammation to 
resolution and as we have shown, the inflammatory mediators which they produce 
and their effect on bystander neutrophils will vary depending on the macrophage 
stimulant. 
Lipopolysaccharide-stimulated monocyte-derived macrophages produced a cytokine 
soup which induced neutrophil apoptosis at early time points.  In this soup, 
soluble TNF-α appeared to be important in mediating this apoptotic effect which 
could be abolished by neutralizing anti-TNF-α antibodies.  To confirm the role of 
TNF-α, future work would assess the effect of blocking antibodies to the TNF 
receptors (TNFR1 and TNFRII) as these are also known to block TNF-α stimulated 
neutrophil apoptosis (Murray et al., 1997).  
As TNF-α appears to be the soluble pro-apoptotic factor, it must be in its trimerized 
form in the cytokine soup as only the fraction containing proteins greater than 
50kD was able to induce apoptosis.  Wound-derived macrophages from rats have 
also been shown to induce neutrophil apoptosis mediated by TNF-α but cell to cell 
contact was required (Meszaros et al., 2000).  Furthermore in a murine model, 
intraperitoneal injection of Leishmania major induced neutrophil recruitment.  
Subsequent neutrophil apoptosis was shown to be induced by membrane-bound 
TNF-α present on macrophages (Allenbach et al., 2006).  
At later time points we showed that the cytokine soup from LPS-stimulated 
macrophages delayed neutrophil apoptosis which may be mediated by TNF-α since 
recombinant TNF-α also delays neutrophil apoptosis at later time points (Murray et 
al., 1997).  However in the lung, other cytokines including GM-CSF and 
macrophage migration inhibitory factor (MIF) may play a role.  MIF has recently 
been shown to delay neutrophil apoptosis (Baumann et al., 2003). 
Chapter 5 
 100
In the lung, GM-CSF appears to play a critical role in the normal functioning of 
alveolar macrophages.  It is important in the terminal differentiation of macrophages 
through induction of the transcription factor PU.1 (Shibata et al., 2001; Berclaz et 
al., 2002).  Furthermore, the alveolar macrophages of GM-CSF knockout mice are 
unable to produce TNF-α in response to LPS (LeVine et al., 1999) and have defects 
in cellular adhesion and phagocytosis (Paine et al., 2001).  Consequently the 
knockout mice have severely impaired clearance of pulmonary bacterial and fungal 
pathogens (LeVine et al., 1999; Paine et al., 2000).  The knockout mice also 
developed a condition that resembled human pulmonary alveolar proteinosis where 
eosinophilic lipoproteinaceous material and large foamy macrophages accumulate in 
the alveoli.  It is now known that this is due to defective catabolism of the surfactant 
proteins by alveolar macrophages and that the acquired form of pulmonary alveolar 
proteinosis in humans is due to GM-CSF neutralizing autoantibodies (Kitamura et 
al., 1999; Yoshida et al., 2001). 
If the LPS-stimulated monocyte-derived macrophages phagocytosed apoptotic 
neutrophils, the macrophages appeared to switch to a more quiescent phenotype and 
their cytokine soup was unable to induce neutrophil apoptosis.  The interaction of 
LPS, apoptotic cells and murine macrophages has been extensively studied.  LPS 
alone triggers TNF-α release over 24 hours.  While phagocytosis of apoptotic cells 
augments the TNF-α at early time points (4-6 hours), at later time points TNF-α 
production is inhibited (Lucas et al., 2003). 
Monocyte-derived macrophages which have phagocytosed apoptotic neutrophils 
express FasL (Brown and Savill, 1999) however the Fas/FasL pathway does not 
appear to be important in inducing neutrophil apoptosis when the macrophages are 
stimulated with LPS.  In neutrophils, Fas ligation does not lead to NF-κB activation 
(figure 4.4a) however in monocytes NF-κB is activated upon Fas ligation and Fas 
ligation in human macrophages stimulates TNF-α production (Park et al., 2003). 
It has been shown in primary human macrophages that interruption of Fas signalling, 
either at the Fas receptor or by expression of dominant-negative FADD, suppresses 
LPS-induced TNF-α secretion.  In the macrophage, LPS signals through the same 
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pathway as in the neutrophil (diagram 4.2).  FADD and MyD88 have death domains 
which promote protein-protein interaction and it was shown in primary macrophages 
that Fas ligation suppressed the interaction of FADD with MyD88 by sequestering 
FADD in the DISC (Ma et al., 2004).  The reverse may be true in neutrophils; 
perhaps MyD88 interacts with FADD preventing it forming the DISC and thus LPS 
inhibits Fas-induced neutrophil apoptosis. 
In rheumatoid arthritis (RA), macrophage number and cytokine expression, including 
TNF-α, strongly correlates with disease symptoms and joint destruction (Feldmann et 
al., 1996; Mulherin et al., 1996; Tak et al., 1997).  In keeping with this, inhibition of 
TNF-α by humanized monoclonal anti-TNF-α antibodies (infliximab) or neutralizing 
anti-TNF-α proteins (etanercept), ameliorate the symptoms and reduce joint 
destruction in RA (Bathon et al., 2000; Lipsky et al., 2000).  This has led to 
widespread use of these agents however the incidence of tuberculosis in treated 
patients has increased four-fold (Wolfe et al., 2004).  Mycobacterium tuberculosis 
finds a haven in macrophages and it is thought, by many in the field, that 
macrophage apoptosis is therefore required to initiate killing of the organism.  As 
this is a TNF-α -dependent process (Rojas et al., 1999), latent TB may become 
reactivated during anti-TNF-α treatment.  However in an animal model of 
immunosuppression-related gram-negative bacteraemia, anti-TNF-α treatment 
reduced circulating bioactive TNF-α but failed to reduce organ damage and mortality 
(Lechner et al., 1997).  It would be interesting to know why anti-TNF-α therapies 
have proved successful in rheumatoid arthritis, Crohns disease and inflammatory 
ocular diseases but so far have not shown benefit in pulmonary disorders including 
ARDS and sarcoidosis.  Is this a function of the phenotype of the alveolar 
macrophage? 
Proteomics in comparison to the study of the genome is in its infancy.  At a cellular 
level 2D gel databases for alveolar macrophages and human monocytes have been 
constructed.  This has allowed analysis of protein changes during differentiation and 
also the effect of smoking, on protein levels in alveolar macrophages, has been 
determined (Wu et al., 2005).  There is also increasing interest in the use of 
proteomics to find markers of disease.  In the field of respiratory medicine, 2D gel 
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electrophoresis has been used to examine differential protein expression in lung 
biopsies and samples from patients with cystic fibrosis, idiopathic pulmonary 
fibrosis, mesothelioma, asbestosis, hypersensitivity pneumonitis and acute lung 
injury (Lenz et al., 1993; Lindahl et al., 1996; Wattiez et al., 2000; Griese et al., 
2001; Bowler et al., 2003).  In idiopathic pulmonary fibrosis and hypersensitivity 
pneumonitis while there was a relative decrease in the quantity of surfactant-A, there 
was a relative increase in transferrin, transthyretin, α1-antitrypsin and 
immunoglobulin (Wattiez et al., 2000).  In cystic fibrosis patients there was a relative 
increase in α1-antitrypsin and lower molecular weight isoforms of surfactant-A 
(Griese et al., 2001).  In acute lung injury, as expected, due to loss of the alveolar-
capillary barrier, there was leakage of high molecular weight proteins such as 
albumin, transferrin and immunoglobulin into the BALF.  As there is loss of type II 
pneumocyte function in ALI, there was also a relative decrease in surfactant-A.  
Acute phase proteins such as serum amyloid A were increased.  Interestingly these 
investigators found that another acute phase protein orosomucoid was post-
translationally modified in ALI and putatively it may reduce neutrophil inflammation 
by binding E-selectin and P-selectin (Bowler et al., 2003). 
In summary, it would appear that TNF-α is important in the interaction between 
inflammatory neutrophils and macrophages.  In rodents, membrane-bound TNF-α is 
required for macrophages to induce neutrophil apoptosis however in a human in vitro 
system, we have shown that soluble TNF-α is important.  However alveolar 
macrophages have specialized to optimize their function for operating in a unique 
microenvironment.  It would therefore be interesting to study, in vitro and in vivo, the 


















Figure 5.1. THP-1 and Neutrophil (PMN) Co-culture. 
 
THP-1 (1x106/ml) in RPMI and 10% Fbs adhered to fibronectin in 12-well plates and were 
stimulated with PMA (1ng/ml) for 24h.  Cells were washed and cultured for 24h in RPMI 
and 10% Fbs before stimulation with LPS (1µg/ml).  PMN (2x106/ml) were cultured with 
THP-1 (THP), LPS-stimulated THP-1 (L.THP.CM), LPS-stimulated THP-1 washed, with 
fresh media (LTHP.FM), control PMN (PMN) and PMN with conditioned media transferred 
from LPS-stimulated THP-1 (PMN.CM).  PMN apoptosis was assessed by Annexin V.  All 
values represent mean + SEM of n = 3 experiments; each performed in duplicate. *p<0.05. 
(a) THP-1 cells were stimulated with LPS for 4 hours. (b) THP-1 cells were stimulated with 






















































Figure 5.2. The effect on neutrophil (PMN) apoptosis of conditioned 
supernatants from LPS-stimulated human peripheral blood-derived 
macrophages (HDM) 
 
(a) Human peripheral blood-derived mononuclear cells (4x106/ml) differentiated in 48 well-
plates (IMDM with 10% AS) for 5 days, were stimulated with LPS (1µg/ml) for 20h.  The 
conditioned supernatants (CM) were fractionated through 50kD Centricon filters.  PMN 
(2x106/ml) were cultured in the 48-well plates with IMDM + conditioned supernatants for 4 
hours.  Apoptosis assessed by morphology (n=3). ***p<0.001. (b) HDMCs (4x106/ml) were 
differentiated in 48-well plates with IMDM and 10% autologous serum (serum) or 
macrophage serum-free medium supplemented with GM-CSF (500U/ml) for 5 days.  They 
were trypsinized and the cells were labelled with anti-CD64 (1:50), anti-DR (1:50), 3G8 
(1:50), My4 (1:50) and isotype control antibodies.  Binding was assessed by flow cytometry 
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Figure 5.3. The effects of fractionation of the conditioned supernatants from 
LPS-stimulated HDM 
(a) Human peripheral blood-derived mononuclear cells (4x106/ml) were differentiated in 48 
well-plates in serum (IMDM with 10% AS) or serum-free conditions (Macrophage-SFM 
with GM-CSF (500U/ml) for 5 days and stimulated for 20 hours with LPS (1µg/ml) + 10% 
autologous serum (AS) or lipopolysaccharide-binding protein (LBP) (15.9µg/ml).  The 
conditioned supernatants (CM) were fractionated through 50kD Centricon filters.  PMN 
(2x106/ml) were incubated in 48-well plates with IMDM + conditioned supernatants for 4 
hours.  Apoptosis was assessed by morphology (n=2). (b) 2D electrophoresis of the 
conditioned supernatants was carried out as described in the methods.  This is a 



































Figure 5.4. The effect of phagocytosis of aged human neutrophils by HDM. 
 
Human peripheral blood-derived mononuclear cells (4x106/ml) differentiated in 48 well-
plates (IMDM with 10% AS) for 5 days, were cultured for 20h + LPS (1µg/ml) + aged 
neutrophils (PMN (4x106/ml) in IMDM and 10% AS which had been incubated overnight) 
(Apop.PMN).  The supernatants were removed and centrifuged to remove cellular debris.  
(a) A cytokine bead assay was used to determine concentrations of various inflammatory 
cytokines in these supernatants as described in the methods. (b) PMN (2x106/ml) in IMDM 





























































Figure 5.5. TNF-α, CM from LPS-stimulated HDM and neutrophil apoptosis 
(a) PMN (2x106/ml) in IMDM and 10% AS were pre-incubated with varying concentrations of anti-
human TNF-α antibody in a shaking water bath for 1 hour.  They were then incubated, in 96 well-
plates, with recombinant human TNF-α (50ng/ml) for 4 hours and apoptosis assessed by Annexin V 
(n=2).  (b) HDMCs (4x106/ml) differentiated in 48 well-plates (IMDM with 10% AS) for 5 days, were 
stimulated for 20h with LPS (1µg/ml).  The conditioned supernatants (CM) were harvested.  PMN 
(2x106/ml) in IMDM and 10% AS were pre-incubated with IMDM + anti-human TNF-α antibody 
(3µg/ml) or ZB4 (500ng/ml) in a shaking water bath for 1 hour.  They were then incubated, in 96 
well-plates, + IMDM or conditioned supernatant (CM) or heat-inactivated CM for 4 hours and 
apoptosis assessed by morphology (n=3, **p<0.01, *** p<0.001).  (c) PMN (2x106/ml) in IMDM and 


































































The alveolar milieu and the activation state of the neutrophil are important 
determinants of neutrophil apoptosis.  Inflammatory neutrophils from LPS treated 
rats were found to be resistant to the induction of apoptosis by anti-Fas antibody 
(Watson et al., 1997).  These studies have also shown in vitro that the inflammatory 
mediators fMLP, lipopolysaccharide (LPS) and GM-CSF inhibited Fas-induced 
neutrophil apoptosis by a mechanism independent of the ERK pathway.  At early 
time points, the LPS-inhibition of Fas-induced neutrophil apoptosis did not appear to 
involve the, PI3-kinase or PKC pathways but this inhibition may be partially 
mediated by p38 MAPK and NF-κB.  The natural prostaglandin metabolite, 
15dPGJ2, is an NF-κB inhibitor (Ward et al., 2002) and in vitro, these studies 
confirmed that 15dPGJ2 attenuated the LPS-mediated inhibition of Fas-induced 
neutrophil apoptosis and associated caspase-8 degradation.  Our studies of signalling 
pathways were limited by only using kinase inhibitors.  Although these inhibitors are 
widely used in scientific studies, their specificity for a particular enzyme is never 
100% (Davies et al., 2000).  Therefore these inhibitors should only be used as fishing 
tools and further work, using immunoblot analysis of phosphorylation of individual 
kinases and/or direct kinase assays, is required to elucidate whether individual 
signalling pathways are indeed involved.  In studying these pathways, it is also 
important to be aware of each inhibitors mechanism of action.  As SB203580 is a 
competitive inhibitor of the ATP-binding site on p38 MAPK, it does not affect the 
phosphorylation of p38 MAPK but affects phosphorylation of its downstream target 
heat shock protein 27 (HSP27) (Cuenda et al., 1995).    
Consistent with this observation, 15dPGJ2 was shown to have a protective role in a 
carageenin model of ALI, (Mochizuki et al., 2005).  However, in a LPS model of 
ALI, although 15dPGJ2 reduced NF-κB activation, 15dPGJ2 enhanced lung injury 
(Inoue et al., 2003).  In endoxaemia-induced ALI, inflammatory neutrophils show 
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increased NF-κB activation compared to peripheral blood neutrophils which leads to 
their expression of pro-inflammatory mediators including IL-1β, IL-8 and TNF-α 
(Shenkar and Abraham, 1999).  In contrast to 15dPGJ2, in a LPS model of ALI, anti-
oxidants have been shown to suppress NF-κB activation and subsequent neutrophilic 
inflammation (Blackwell et al., 1996). 
In neutrophils, p38 MAPK partially mediated the anti-apoptotic effect of LPS on 
Fas-induced neutrophil apoptosis.  In murine models, inhibition of p38 MAPK prior 
to haemorrhagic shock or endotoxaemia, did not decrease lung injury (Arcaroli et al., 
2001) whereas systemic administration of a p38 MAPK inhibitor after intra-tracheal 
LPS reduced neutrophilic inflammation in the lung (Nick et al., 2000).  In humans, a 
p38 MAPK inhibitor has also prevented the deleterious effects of endotoxaemia 
(Branger et al., 2002). 
In studies of the Fas/FasL pathway, the most commonly used activating anti-Fas 
antibody is CH-11.  We found that the potency of individual batches of CH-11 
decreased over time even despite aliquoting the antibody to reduce freeze/thaw 
cycles.  Therefore a single experiment was repeated over a short period to minimize 
this effect.  This observation explains the wide variation in the apoptosis-inducing 
effect of CH-11 seen in our studies.  However there was less inter-subject variation 
in the neutrophil response to CH-11 unlike the large inter-subject variation in 
neutrophil response to TNF-α which other groups have found (Walmsley et al., 
2004). 
The inhibitory effect of LPS was prevented if the Fas-signalling pathway was first 
activated.  We have been unable to dissect the signalling pathways involved using a 
modified immunoprecipitation technique however the adapter molecule cFLIP is a 
potential candidate.  In acute lung injury, contrary to our hypothesis, other groups 
have now shown that the Fas/FasL pathway actually has a pro- rather than anti-
inflammatory role.  In a murine model, intratracheal instillation of a Fas-activating 
antibody induced neutrophilic lung inflammation.  There are several reasons why 
activation of the Fas/FasL pathway may be pro-inflammatory in vivo.  As well as 
inducing apoptosis, in human airway epithelial cells and human monocyte-derived 
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macrophages, Fas can activate NF-κB leading to secretion of pro-inflammatory 
cytokines including IL-8 (Hagimoto et al., 1999; Park et al., 2003).  The soluble 
form of FasL (sFasL) is also chemotactic for neutrophils and induces apoptosis in 
distal lung epithelial cells (Matute-Bello et al., 1999).  However a recent study 
suggests that the Fas-expressing alveolar epithelium appears to be the primary target 
in this model (Matute-Bello et al., 2005).  In patients with ALI/ARDS the expression 
of Fas/FasL is also upregulated in lung tissue (Albertine et al., 2002).  The lung 
injury induced by Fas/FasL can be ameliorated by the analogue of the natural FasL 
antagonist, decoy receptor 3 (Wortinger et al., 2003).  After haemorrhagic shock and 
sepsis, Fas-small interfering RNA (siRNA) but not caspase-8 siRNA, reduced the 
extent of lung injury including pulmonary epithelial cell apoptosis and neutrophilic 
inflammation (Perl et al., 2005).  Thus Fas-small interfering RNA (siRNA) might be 
a novel treatment for sepsis-induced ALI (Wesche et al., 2005). 
In the lung, the alveolar macrophage is not only important in bacterial phagocytosis, 
it also phagocytoses apoptotic neutrophils and is important in regulating the cytokine 
profile of the alveolar milieu.  We have shown that LPS-activated monocyte-derived 
macrophages induce neutrophil apoptosis at early time points due to their production 
of soluble TNF-α.  We have also confirmed that these LPS-activated macrophages 
which have phagocytosed apoptotic neutrophils downregulate their production of 
pro-inflammatory cytokines such that their conditioned supernatants are no longer 
able to induce neutrophil apoptosis.  In quiescent macrophages, phagocytoses of 
apoptotic neutrophils appears to stimulate FasL expression and their conditioned 
supernatants containing sFasL induce neutrophil apoptosis at later time points than 
studied here (Brown and Savill, 1999).  We found that Fas/FasL was not involved in 
the neutrophil apoptosis induced by LPS-activated monocyte-derived macrophages at 
early time points.  The cellular microenvironment may also be important in 
determining the pattern of cytokines released by LPS-activated macrophages and 
also their effect on neutrophil apoptosis.  In rat alveolar macrophages cultured in 
vitro, increasing the CO2 concentration decreased early TNF-α release (Lang et al., 
2005). It would be interesting to investigate the response of human alveolar 
macrophages under different culture conditions. 
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Elegant proteomic studies have not only shown how alveolar macrophages differ 
from their precursor blood monocytes but also how they differ in various lung 
diseases (Wu et al., 2005).  In ARDS, alveolar macrophages have been phenotyped 
and whilst there was no evidence of resident alveolar macrophage proliferation, early 
BALF samples showed abundant monocyte-like alveolar macrophages associated 
with elevated MCP-1 levels.  In patients who demonstrated less lung injury manifest 
by better gas exchange, MCP-1 levels declined earlier associated with a switch in the 
BALF from the predominance of monocyte-like alveolar macrophages to the mature 
alveolar macrophage phenotype (Rosseau et al., 2000).  In studying alveolar 
macrophages in vitro, mimicking their lung microenvironment is important.  For 
example, human alveolar macrophages have only been shown to express nitric oxide 
synthase type-2 (NOS2) when co-cultured with human alveolar type-II epithelial 
cells in the presence of IFN-γ.  Surfactant protein A (SP-A) is also important for 
alveolar macrophage function however its production of nitric oxide appeared to be 
independent of SP-A  (Pechkovsky et al., 2002).  Future work would therefore 
involve the study of human alveolar macrophages from different stages of ARDS, in 
the presence of different cytokines and to examine the effect of co-culture with 
human alveolar type-II epithelial cells.  
There are many large randomised clinical control trials investigating management 
options in the treatment of sepsis, ALI and ARDS.  In severe sepsis, recombinant 
activated protein C (rhAPC) has been shown to improve mortality (Ely et al., 2003).  
As well as being a natural anticoagulant, inhibiting activated factor V and VIII of the 
clotting cascade, activated protein C also has anti-inflammatory properties including 
inhibition of neutrophil adhesion to vascular endothelium (Uchiba et al., 1996) and 
reduction in LPS-stimulated production of TNF-α by monocytes (Grey et al., 1994).  
Recently the effect of rhAPC on neutrophil function after LPS has been instilled in a 
human lung segment was determined.  Neutrophil accumumation in response to 
endobronchial LPS was reduced and isolated blood and BALF neutrophils showed 
reduced chemotaxis in response to IL-8 in vitro.  Neutrophil function was otherwise 
normal in these healthy volunteers treated with rhAPC (Nick et al., 2004).  However 
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the main anti-inflammatory effect of rhAPC in sepsis is probably due to decreased 
endothelial cell stimulation. 
Mortality in ARDS has improved.  Lung protective ventilation strategies are now 
universally applied in the management of patients with ALI (ARDS, 2000).  The 
aetiology of ventilator-induced lung injury has largely been determined in the 
laboratory.  Application of physical forces to cultured alveolar epithelial cells 
stimulates production of cytokines, chemokines and other inflammatory mediators 
(Dreyfuss and Saumon, 1998).  A conservative strategy to fluid management has also 
proved beneficial in improving lung function and central nervous system function but 
there was no benefit in mortality (Wiedemann et al., 2006).  No benefit from prone 
ventilation or treatment with recombinant surfactant has been shown (Spragg et al., 
2004; Fan et al., 2005). 
In summary, we, like others, have refuted the earlier findings of FasL expression on 
neutrophils and the Fas/FasL pathway does not appear to be important in 
spontaneous neutrophil apoptosis.  At inflammatory sites, neutrophils are unlikely to 
be susceptible to Fas-induced apoptosis as inflammatory mediators inhibit Fas-
induced neutrophil apoptosis in vitro.  Furthermore there are many studies suggesting 
that activation of the Fas/FasL pathway on non-myeloid cells in the lung appears to 
be pro-inflammatory.  Cross-talk between intracellular survival and death pathways 
in the neutrophil and the role of cFLIPs is worthy of further study.  The use of small 
interfering RNA in the field of medical therapeutics is rapidly developing and these 
pathways are attractive targets to enhance neutrophil apoptosis in the inflamed lung.  
Further elucidation of the interaction between the alveolar macrophage and 
neutrophil at different time points in the course of acute lung injury may also lead to 
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